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ABSTRACT 
 
 
Roles of cyclic nucleotides and cyclic nucleotide-dependent signaling molecules 
in regulating several signaling pathways including cell migration have long been known. 
However, the new and revolutionary concept is that it is not just the absence or presence 
of cyclic nucleotides, but a highly coordinated balance between these molecules regulates 
cell migration. Multi-drug resistance protein 4 (MRP4), is a member of the large family 
of ATP binding cassette (ABC) transporter proteins, that localizes to the plasma 
membrane and functions as a nucleotide efflux transporter and thus plays a pivotal role in 
the regulation of intracellular cyclic nucleotide dynamics. In our study we used MRP4-
expressing fibroblast cells and MRP4 knockout mice as model systems and wound 
healing assays as the experimental system to explore this unique and emerging concept. 
Here we demonstrated for the first time that mouse embryonic fibroblasts (MEFs) 
isolated from Mrp4
-/-
 mice have higher intracellular cyclic nucleotide levels and migrate 
faster compared to MEFs isolated from Mrp4
+/+
 mice. Using FRET based sensors 
specific for cAMP and cGMP we showed that inhibition of MRP4 with MK571 
moderately increases both cAMP and cGMP levels and enhances the cell polarization 
leading to an increased cell migration. Whereas a robust increase in cAMP levels was 
observed following treatment with forskolin and IBMX, which causes decreased 
fibroblast migration. Cell migration appeared to be biphasic in response to externally 
added cell-permeant cyclic nucleotides (cpt-cAMP and cpt-cGMP). Furthermore we 
identified actin as an integral part of MRP4-interactome and these two proteins associate 
with each other predominantly at the plasma membrane. We also observed that actin 
cytoskeleton restricts MRP4 to the specific micro-domains of plasma membrane. Using 
FRET based sensor we showed that Mrp4
-/-
 fibroblasts are more polarized compared to 
the Mrp4
+/+
 cells with a higher compartmentalized cAMP levels and PKA activities near 
the leading edge, which in turn lead to an enhanced cortical actin polymerization at the 
cell front. Taken together our studies suggested a novel cAMP-dependent mechanism for 
MRP4-mediated regulation of fibroblast migration where PKA and actin play critical 
roles as downstream targets. 
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CHAPTER 1.    MRP4 IN HEALTH AND DISEASE 
 
 
An Overview of the Drug Transporter Family 
 
The absorption, distribution and excretion of drugs largely depend on the uptake 
and efflux drug transporters which control drug transport in and out of the cell 
respectively (1,2). The virus-independent and alternative mechanism of drug resistance 
relays on the expression and tissue-specific distribution of the efflux transporters. 
 
 
ATP binding cassette transporters 
 
The ATP binding cassette (ABC) transporters are predominantly located on the 
plasma membrane and are involved in the extrusion of structurally diverse drugs and their 
metabolites. Based on their two dimensional structure at the plasma membrane, they can 
be classified into four distinct groups (i) P- glycol protein (P-gp), (ii) MRP1,2,3, (iii) 
MRP4,5 and (iv) BCRP (1). These ABC transporters utilize the energy from ATP 
hydrolysis to export their substrate against the concentration gradient. These active 
transporters are thus capable of regulating the pharmacological behavior of drugs, drug 
metabolites, drug conjugates, xenobiotics and the consequence of this altered drug 
availability on the well-being of individual patients (3). 
 
 
Multi-drug resistance protein 
 
The multi-drug resistance protein (MRP) family currently has nine members 
among which MRP1-8 are membrane localized. As organic anion transporters, MRPs 
have diverse substrate populations among a wide range of anticancer and antiviral drugs 
and thus are responsible for conferring most of the drug resistances during the period of 
treatment (4). MRPs were first identified by Cole and group in 1992 as a second type of 
drug pump beside the already studied P-gps (5). Unlike P-gps which only confer 
resistance against neutral or slightly basic organic compounds, MRPs are more versatile 
and can transport GSH, glucuronate or sulfate-conjugated drugs, organic anions like 
methotrexate and several nucleoside analogues such as PMEA. The wide range of 
substrate specificities including small molecules make MRPs prime targets to ameliorate 
the unwanted effect of drug resistance (4). 
 
 
Structure and Function of MRP4 
 
Multi-drug resistance protein 4 (MRP4) is an ABC transporter that is localized 
predominantly at the cell membrane (6). Together with cystic fibrosis transmembrane 
conductance regulator (CFTR), it belongs to the ABCC subfamily. In 1999 it was first 
identified as an efflux transporter of nucleoside-based antiviral drugs in T-lymphoid cell 
lines (7). 
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MRP4/ABCC4 gene 
 
MRP4 is the shortest member of the ABCC subfamily and contains only 1325 
amino acids. It is encoded by the MRP4/ABCC4 gene that is located on chromosome 
13q32.1. (3,8). The highly polymorphic MRP4 gene is comprised of 31 exons and 30 
introns (9). Single nucleotide polymorphisms (SNPs) of the gene may lead to alterations 
of expression, function and substrate specificity of MRP4. At least 25 non-synonymous 
SNPs have been identified for MRP4 and those variants are clinically important for the 
inter-patient variability of drug resistance. Exons 1a and 1b of the MRP4 gene can 
undergo alternative splicing independently or in combination. Sometimes the alternative 
splicing may lead to nonsense mutations due to premature termination codons (PTC) in 
the mRNA transcripts (10). MRP4 expression can be regulated by these mechanisms 
based on the specific cellular and molecular environments. Remarkably these PTC 
producing exons are highly conserved in evolution for the truncated and non-functional 
MRP4 encoding gene. 
 
 
Structure of MRP4 
 
1325 amino acids-long MRP4 consists of a conserved PDZ-binding motif at the 
40 amino acid long C terminus. Structurally MRP4 has two membrane-spanning domains 
(MSDs) and two cytosolic nucleotide-binding domains (NBDs) (11). Each membrane-
spanning domain consists of six transmembrane helices (TMs). The NBDs bind and 
hydrolyze ATP. The energy evolved by ATP hydrolysis, facilitates the substrate 
transportation by MRP4 against the diffusion gradient. The phenylalanine residues at 
positions 368 and 369 and glutamic acid residues at positions 374 and 387 in the highly 
conserved TM6 are unique among MRP4s of different species but are not conserved for 
other MRPs. The functionally important positively-charged arginine residues at position 
375 and 782 are also absent in other MRPs. The homology model for MRP4 based on the 
structure of other extensively-studied related MRPs indicated that these two arginine 
molecules face into the pore at the membrane cytosol interface and probably play 
important roles in substrate binding (1,3,8). Structure of MRP4 is shown in Figure 1-1. 
 
 
Localization of MRP4 
 
MRP4 is predominantly localized to the plasma membrane of multiple cell types. 
It possesses differential tissue distributions with significant expressions in intestine, 
blood capillaries, brain, liver, placenta and kidneys (3). As an efflux transporter MRP4 
plays an important role in tissues with barrier functions like blood vessels. Expression of 
MRP4 in lung microvessels is shown in Figure 1-2. An altered tissue distribution and 
elevated expression of MRP4 were reported in several pathologic conditions including 
prostate cancer (12-14). In contrast reduced mRNA level of MRP4 was reported for 
malignant prostrate tumors. Susceptibility of MRP4 deficient mice for obstructive 
cholestasis indicates the importance of the protein in regulating hepatic bile secretion 
(15). 
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Figure 1-1. Structure of MRP4 protein 
 
MRP4 protein topology showing several domains: two membrane spanning domains 
(colored in pink) and two nucleotide binding domains (colored in yellow). 
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Figure 1-2. Expression of MRP4 in lung microvessels 
 
Confocal images showed immunofluorescence of MRP4 (green) and nucleus (blue) in the 
lung micro-vessels of mouse (left panel) and rat (right panel).  
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Unlike other ABCC transporters, MRP4 exhibits dual membrane localization in 
polarized cells. In contrast to renal proximal tubes where it is expressed at the apical 
membrane, MRP4 was reported to be localized to the basolateral membrane of prostrate 
tubuloacinar cells, hepatocytes and choroid plexus epithelial cells. In colonic epithelium 
cells MRP4 was found to be present in both apical and basolateral plasma membranes (6) 
whereas for brain capillaries the expression was reported to be in the luminal side of the 
endothelium (16). 
 
 
Substrates of MRP4 
 
MRP4 is a member of ABC transporter family and it utilizes the energy of ATP 
hydrolysis for the active efflux of its substrates (8,17). A diverse group of drugs and 
endogenous compounds can be transported by MRP4 depending on the tissue distribution 
and cellular environment in the vicinity of MRP4 molecules. In T lymphoid cell line, it 
was first identified as an endogenous efflux transporter of nucleoside based antiviral 
drugs like AZT, PMEA and Adefovir (7). Several anticancer drugs like MTX and 
topothecan also showed MRP4-dependent transportation. The inhibitors of MRP4 (e.g. 
MK571, sildenafil, probenecid) also act as substrates for MRP4 and competitively inhibit 
the MRP4-mediated efflux of other substrates but they lack the specificity. MRP4 also 
has a large number of endogenous substrates like cAMP, cGMP, bile acids, 
prostaglandins, urate etc. Substrate binding sites allosterically regulate the transporter 
activity of MRP4 presumably in a complex manner. For example previous reports 
revealed that MRP4 binding of urate inhibits MTX efflux but stimulates cGMP transport 
whereas cAMP transportation remains unaltered (18) indicating the presence of multiple 
substrate binding sites in MRP4 structure (3). 
 
 
MRP4-Dependent Cell Signaling 
 
Several physiologically important molecules which are involved in diverse 
intracellular and extracellular signaling pathways were found to be transported by MRP4. 
By altering their cellular levels, MRP4 can regulate several signaling processes typically 
in a compartmentalized fashion. This warrants the eligibility of MRP4 as a new 
therapeutic target for several pathophysiological conditions. 
 
 
Effect of MRP4 on cyclic nucleotide-mediated signaling 
 
The small but elegant second messengers, cAMP and cGMP, are the first 
identified endogenous substrate for MRP4 (19-21). MRP4 has very high affinities for 
both cAMP and cGMP and the Km values obtained in vitro for cAMP and cGMP were 
45µM (19) and 10/ 180 (18,19) respectively. However the affinities are highly variable 
depending on the specie. Both cAMP and cGMP are important second messengers which 
can regulate diverse cellular signaling processes via activation of their corresponding 
protein kinases, PKA and PKG respectively. Though the existence of specific receptors 
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for these cyclic nucleotides is still controversial, there are evidences indicating an active 
transportation of cAMP and cGMP out of the cells. This probenecid sensitive efflux 
mechanism is responsible for cyclic nucleotide or their active metabolite mediated intra 
and extracellular signaling in a paracrine manner (22). As MRP4 is capable of 
transporting cyclic nucleotides, it could regulate the intracellular and extracellular 
concentrations of cyclic nucleotides along with different isoforms of phosphodiesterase 
(PDEs). The whole cell concentrations of cyclic nucleotides are found to be slightly 
altered in the absence of MRP4 in fibroblasts and pulmonary smooth muscle cells 
(17,23). 
 
In recent years increasing evidences are suggesting that the cyclic nucleotide-
dependent signalings are highly compartmentalized (24,25). Being a membrane protein, 
MRP4 plays a critical role in regulating the compartmentalized cyclic nucleotides near or 
at the plasma membrane. This fine-tuned localized modulation near the MRP4 molecules 
directs the specific signaling flow rather than a global wave. For example, a 
macromolecular complex between CFTR and MRP4 at the apical membrane regulates the 
secretory properties of gut epithelia whereas in cardiac myocytes, this interaction plays 
an important role for β-adrenergic-stimulated contraction. Both occur via the 
compartmentalized alteration of cAMP dynamics (6,26). In the kidney MRP4 mediates 
secretions of cAMP and cGMP into the primary urine and these secreted cyclic 
nucleotides regulate the downstream signaling events either directly or via their 
metabolites. This mechanism is important for maintaining water and salt homeostasis 
(27). In addition, the absence of MRP4 altered the cAMP dynamics in leydig cells and 
thus an attenuated luteinizing hormone-regulated testosterone production was observed in 
Mrp4
-/-
 mice (28). Since some of the PDE inhibitors like sildenafil and dipyrimadole are 
also potent inhibitors of MRP4, some of those drugs’ effects can also be mediated 
through MRP4 inhibition (29). 
 
 
Effect of MRP4 on urate and eicosanoids-mediated signaling 
 
Among the endogenous substrates urate and eicosanoids are also important 
substrates for MRP4. In human body the end product of purine metabolism is urate which 
regulates the free radical scavenging and immune response by conferring a danger signal. 
In the kidney, together with the apical urate uptake transporter URAT1, MRP4 can 
regulate the bidirectional renal handling of urate and hence can be a potential target for 
the treatment of hyperuricaemia (30,31) . MRP4 can control the urate levels in blood 
cells, liver, vascular smooth muscles and intestine as well by regulating the basolateral or 
luminal efflux of urate. 
 
Though eicosanoids like leukotrienes (LTB4 and LTC4) and prostanoids (PGE1, 
PGE2 PGF2α and thromboxane B2) have very low affinity for MRP4, the eicosanoids-
mediated important extracellular signaling process can be regulated by MRP4 in normal 
physiological or pathological conditions (32,33). As some of the nonsteroidal anti-
inflammatory drugs can also inhibit MRP4, in addition to inhibit prostaglandin synthesis, 
they can exert their effect by attenuating the prostaglandin secretion by MRP4. In 
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addition, MRP4-deficient mice were found to exhibit a higher inflammatory pain 
threshold and reduced prostanoids metabolites with altered cAMP dynamics (34). 
 
Utilizing the energy of ATP hydrolysis, MRP4 is capable of transporting a wide 
range of endogenous substrates like cyclic nucleotides and eicosanoids which play 
important roles in the intra- and inter- cell signaling. A comprehensive exploration of 
MRP4 mediated cellular signaling is important to understand the contribution of MRP4 in 
health and disease. 
 
 
Role of Cyclic Nucleotides in Cell Signaling 
 
In the year of 1971, Dr. Eark W. Sutherland won the Noble prize for identifying 
the first member of the family of secondary messengers- cyclic adenosine 
monophosphate (cAMP) (35,36). Thereafter for more than 40 years cAMP and cGMP 
have been recognized as important signaling molecules that regulate a myriad of 
physiological processes like cell growth, migration, adhesions, fluid secretion, 
metabolism, neuronal signaling and many more. An altered cyclic nucleotide signaling is 
often associated with pathological conditions like cancer, fibrotic diseases, metabolic 
diseases, neuronal disorders and defective immune response.(20,24,37,38). These simple 
but elegant molecules carry the external signals inside the cell as secondary messengers. 
Depending on the cell types, cell environment, localization and intensity of signal, they 
can elicit different intracellular events in response to the same external cue (24). 
 
 
Synthesis and regulation of cyclic nucleotides 
 
Cyclic nucleotides, cAMP and cGMP, are synthesized from their nucleotide 
triphosphate precursors (ATP and GTP) by the action of adenylyl cyclase (AC) and 
guanylyl cyclase (GC) respectively. These cyclase catalysts are found in both cytosolic 
soluble and particulate transmembrane forms (20,39,40) representing intracellular but 
segregated populations of cyclic nucleotides. Nine membrane-bound and one cytosolic 
AC isoforms have been identified. Similarly for GCs seven particulate and a single 
soluble isoforms were found. The majority of the ACs get activated indirectly by ligands 
like adrenergic agonists that bind to G protein couple receptors (GPCRs) and induce the 
disassociation of Gαs subunit which in turn activates AC for cAMP synthesis. In contrast, 
GCs get activated directly by their stimuli like natriuretic peptides, small paracrine 
peptide hormones, cytokines (specific for particulate isoforms) and nitric oxide (specific 
for the soluble isoform) (37,41,42). 
 
After synthesis the cyclic nucleotides are degraded by the different isoforms of 
phosphodiesterase (PDEs) to their corresponding mono phosphates (AMP and GMP). 
Eleven different types of PDEs have been identified in mammalian cells. Among them 
PDEs 4, 7 and 8 are specific for cAMP where as PDEs 5, 6 and 9 are specific for cGMP 
and PDEs 1, 2, 3, 10 and 11 exhibit dual specificities for cAMP and cGMP. The diversity 
of PDE isoforms ensure characteristic cyclic nucleotide dependent signaling in diverse 
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cell or tissue types. Their subcellular localization and specific association with effector 
and adaptor proteins also determine the compartmentalization of signaling events 
involving cAMP and cGMP (24,38). Endogenous efflux transporters of cAMP and cGMP 
(MRP4 and MRP5) play pivotal roles in this aspect. By regulating the active 
transportation they can affect the global and subcellular concentration of cyclic 
nucleotides and thus modulate various cyclic nucleotide-dependent biological processes 
(17,20). 
 
 
cAMP-dependent cell signaling 
 
Depending on the cell type and subcellular localization, cAMP exerts its effect 
primarily via activation of the cAMP-dependent kinase PKA and the exchange protein 
activated by cAMP (EPAC). It can also directly activate the hyperpolarization-activated 
cyclic nucleotide gated channels (HCN) and cyclic nucleotide gated channels (CNG) with 
or without altering the membrane potentials. These channels play important roles in 
cardiac rhythm, and olfaction (41). By activating EPAC which is a guanine nucleotide 
exchange factor (GEF), cAMP can mediate several anti- and pro-apoptotic processes, 
hormonal signaling, cardiac contraction and vascular permeability through PKA 
independent mechanisms (43). EPAC can also activate the small G protein called RapI, to 
mediate cell migration, adhesions, junction formation and secretions (41). 
 
The holoenzyme PKA consists of two regulatory (R) and two catalytic subunits 
(C). Upon cAMP binding PKA releases the active catalytic subunits which phosphorylate 
their downstream target at serine/threonine residues. Four different R subunits (RIα, RIIα, 
RIβ and RIIβ) and three catalytic subunits (Cα, Cβ and Cγ) can combine with each other 
to form tetramers with two regulatory and two catalytic subunits and can exhibit 
differential sensitivity, tissue distribution, subcellular localization and cellular response. 
One key downstream effector of PKA is the basic/leucine zipper transcription factor 
CREB which gets phosphorylated at serine 133 by PKA. The phosphorylation induces 
the interaction between CREB and co-activator CBP and subsequent regulation of genes 
involved in metabolism, signaling, proliferation, differentiation, oncogenesis and survival 
(44). 
 
 
cGMP-dependent cell signaling 
 
The key mediator of cGMP-dependent signaling is cGMP dependent kinase PKG. 
The specificity of the responses is largely determined by the subcellular localization of 
cGMP and its effectors. In normal physiological conditions the concentration of cGMP is 
ten-fold less than that of cAMP (45) and cGMP can activate a distinct population of 
effectors for segregating its response from cAMP. The effects of cGMP on CNG are 
important for regulation of photo transductions, natriuresis and water/electrolyte 
homeostasis. 
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PKG is a serine/threonine protein kinase which consists of homodimer of two 
identical subunits. There are three PKG isoforms have been identified till date- PKGIα, 
PKGIβ and PKGII. All the isoforms are widely distributed but exhibit specificity. PKGIα 
is mainly located in lung, heart, cerebellum and platelets where in smooth muscles of 
uterus, trachea and intestine both PKGIα and PKGIβ can be found and expression of 
PKGII is restricted in brain, intestine and kidney. Different isoforms of PKG can regulate 
diverse signaling processes involve in calcium activation, platelet aggregation, smooth 
muscle contraction, cardiac regulation and gene expression. One of the critical 
downstream effectors of PKG is β-catenin that regulates TCF/LEF mediated 
transactivation and tumorigenesis (37,46). 
 
 
Crosstalk between cAMP- and cGMP-dependent signaling processes 
 
The complexity of cyclic nucleotides-dependent signaling pathways emerges from 
the ability of cGMP to regulate the activity of PDE2 and PDE3 that can hydrolyze cAMP 
with a higher affinity than cGMP. The aldosterone secretion by atrial natriuretic peptide 
(ANP) is induced by a reduction in cAMP levels due to the cGMP mediated activation of 
PDE2 (37,47). 
 
An additional level of complexity arises by the crosstalk between PKA- and PKG-
mediated pathways. They share some common substrates that act as critical downstream 
effectors in both cAMP- and cGMP-dependent signaling. Vasodilator-stimulated 
phosphoprotein (VASP) can be phosphorylated by PKA at serine residue 157 and by 
PKG at residue 239 and exerts differential effects on modulating focal adhesions, cell 
migration, cell shape and platelet aggregation in response to external stimuli (48,49). In 
addition, the activation of PKA and PKG by alternative cyclic nucleotides can also exert 
dichotomous effect on complex signaling events. 
 
The primary focus of this study is to monitor the flow of MRP4-dependent 
biological processes like cell migration in real time and space. We wanted to understand 
the role of MRP4 in regulating intracellular cyclic nucleotide dynamics in fibroblast cells 
and how these altered cyclic nucleotide levels can critically influence the overall process 
of cell migration. 
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CHAPTER 2.    MECHANISM OF CELL MIGRATION 
 
 
Cell migration is a byzantine process that required a concerted cross talk between 
cell adhesion, cytoskeleton organization and membrane extensions. Traditionally the 
process of cell migration consists of four distinct steps- 1) formation of leading edge 
protrusions, 2) adhesion of the leading edge to the extracellular matrix (ECM), 3) forward 
translocations of the cell body and 4) retraction of the trailing edge by releasing the 
attachment at the cell rear (50,51). 
 
The spatial regulation of the intracellular signaling can dynamically regulate the 
segregation of the biochemical events that ensures an efficient cell migration. 
Extracellular signals can be sensed and communicated inside the cell by specific 
receptors which in turn direct the cell to extend membrane protrusions via actin 
polymerization. Establishment of polarity is very important for directional cell migration 
and the spatial distribution of signaling molecules and compartmentalized signaling play 
critical roles in directing cell movement. The adhesive biomolecules aggregate at the cell 
front to facilitate the tethering of the cell protrusions to the substrum whereas the removal 
of those molecules from the cell rear helps in the detachment of the trailing edge. In 
addition the preferential contraction of actomyosin at the cell front pulls the cell body in 
forward direction. However several regulatory steps are involved in directional cell 
migration and dysregulation of any of those steps leads to catastrophic consequences 
(52). The two main theories for directional cell migration are- 
 
 Cytoskeletal model- there are rapid actin polymerization at the cell front and 
extensive interaction of cytoskeleton elements with the plasma membrane (53). 
 
 Membrane flow model- extension of the leading edge occurs primarily by 
addition of new membrane at the front of the cell. Actin filaments stabilize the 
added membrane so that a structured extension or lamella can be formed (54). 
 
The migratory phenotypes are determined by interaction between cell and the 
environment. The fast moving cells (maximum migration speed up to 10 µm/min) like 
immune cells and tumor cells do not have highly organized cytoskeleton and possess 
weak adhesion properties. Thus they can move in a fast amoeboid fashion. In contrast the 
slow moving cells like fibroblast and epithelial precursors (maximum migration speed 1 
µm/min) exhibit elaborate cytoskeleton structures and adhesions (51). However these two 
cell types can switch between each other and can also move in groups depending on the 
external cues. 
 
 
Importance of Cell Migration 
 
Directed cell migration accompanies us from birth to death. Not only implantation 
but also morphogenesis throughout the embryonic development requires well-
orchestrated migratory phenomena. In adults cell migration also regulates the immune- 
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surveillance and the tissue repairing process. The importance of cell migration is not 
limited to human but is extended to unicellular and multicellular organisms and even to 
plants (50). Cell types and migration conditions are the key determinants of mode of cell 
migration although some effectors unanimously regulate migration regardless of the cell 
type and mode of migration. 
 
 
Embryonic developments 
 
Life begins with a single zygote after the union of a sperm and egg cell. After 
conception the zygote transforms into the blastocyst that consists of a ball of rapidly 
dividing cells. This blastocyst migrates to the uterus. Placenta is formed for providing 
nutrition to the developing embryo. Regulated migration of a large group of cells into the 
blastocyst leads to gastrulation. Cells from various layers of gastrula eventually go 
through strategic migration for development of different organs. For example, during 
brain development primitive neuronal cells migrate at different layers, extend projections 
as axons and dendrites and form synapses to allow complex learning and memory process 
(55). This migratory developmental process accompanies us throughout the life and even 
contributes to our death (50). 
 
 
Wound healing 
 
Wound healing is an intricate homeostatic process that comprises of four 
sequential steps (1) hemostasis (2) inflammation, (3) proliferation and (4) remodeling 
(56,57). Lack of proper cell migration leads to a defective would repair. Tissue injury 
initiates mechanical signal as well as the chemotactic molecule secretions that attract 
cells into the injured area. It also triggers the blood factor induced cascade of 
inflammatory signal. In response to injury induced inflammation, fibroblasts first migrate 
into the wound site and produce new, provisional extracellular matrix for facilitating 
epithelialization (58). 
 
Angiogenesis, collagen deposition, epithelialization and wound contraction by 
myofibroblasts are the hall mark steps in the proliferative stage whereas in remodeling 
stage the collagen rearrangements and apoptotic removal of unwanted cells are taken 
place. Wound healing requires complex collaborative efforts of many cell types for 
proliferation, migration, matrix synthesis and contraction (59). 
 
 
The process of wound repair. Depending on the depth of wound various cell 
types like fibroblasts, blood vessels, connective tissue, bone and cartilages get exposed. 
After initial sealing by fibrin blood clot, platelets are recruited to the injury site where 
they release the platelet-derived-growth factor (PDGF). Chemotactic PDGF induce the 
recruitment of other inflammatory cells and stimulate the migration of fibroblasts, 
epithelial and endothelial cells into the wound area. 
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The inflammatory cells like neutrophils and leukocytes rapidly destroy the 
pathogens in the wound site and activate the local fibroblasts and keratinocytes by 
secreting proinflammatory cytokines. The cytokines like interleukin I (IL-I), Tumor 
necrosis factor-α (TNF-α) amplify the neutrophil- and platelet-derived proliferative 
signal. Eventually those neutrophils are replaced by macrophages which produce the 
growth factors and cytokines to facilitate the process of wound healing (56,60). 
Numerous cell-signaling events are required for this efficient and highly controlled 
repairing process. 
 
 
Origin of fibroblasts. Migration and proliferation of fibroblasts dynamically 
regulate the entire process of wound healing. Fibroblasts are derived from mesenchymal 
origin and they are the major component of connective tissue in most vertebrates. In 
contrast to myocytes that form collagen IV, fibroblasts are responsible for producing 
interstitial collagen I, III, IV and IV (61) and can be classified based on their 
morphological and proliferative characteristics. They lack basement membrane and have 
multiple sheet-like processes and extensions. Their oval nucleus contain 1or 2 nucleoli. 
Their cytoplasm consists of a lot of granular material, rough endoplasmic reticulum and 
prominent Golgi apparatus. Fibroblasts are pleomorphic, highly motile cells that contain 
actin and myosin. Their contractility largely depends on the mechanical parameters of 
surrounding environments. 
 
 
Role of fibroblasts in wound healing. Migration of fibroblasts into the wound 
area to produce new interstitial collagen and extracellular matrix (ECM) is a very critical 
step for the repair process. Fibroblasts, for wound repair, mainly come from the 
proliferation of the nearby connective tissue rather than from the recruitment of 
circulating vascular precursors (62). At the late healing phase, fibroblasts start 
proliferating after activated by the chemotactic cytokines TGF-α and TGF-β. These 
activated fibroblasts lead to an increased synthesis of single strand collagen that get 
polymerized and cross-linked in the newly synthesized metalloprotein-rich EM (63). At 
this stage a population of fibroblasts transform into myofibroblasts that resemble smooth 
muscle cells for their high content of α-smooth muscle actin. Myofibroblasts are usually 
formed under tensile condition and are capable of generating high contractile force to 
augment the wound closure (60,64). 
 
 
Role of fibroblast in fibrosis. Fibrosis can be defined as replacement of normal 
tissue structure by excessive accumulation of nonfunctional scar tissue. Transformation 
of fibroblasts- to- myofibroblasts is controlled by a variety of growth factors, cytokines 
and mechanical stress. Recently cAMP has been reported to inhibit the fibroblasts- to- 
myofibroblasts transformation in cardiac fibroblasts (65,66). This process plays a key 
role in wound healing and maintenance of tissue homeostasis. But an increased number 
of myofibroblasts, that express higher level of α-smooth muscle actin, lead to 
overproduction of collagen. Collagen is the most abundant protein that provides strength, 
structure and integrity to the normal tissue. In injured tissue, collagen involves in 
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repairing and restoration of the structure and function. But excess deposition of collagen 
leads to tissue fibrosis. Strategies have been applied to attenuate collagen synthesis for 
preventing the unwanted tissue fibrosis (66,67). 
 
 
Immunity 
 
Immunity is another homeostatic process that depends on cell migrations. Cells of 
immune system (mainly leukocytes) are recruited to the injury site or to the invading 
microorganisms from the circulation. They phagocytize these microbes and destroy them 
by potent digestive enzymes. The constant surveillance by the circulating immune cells 
protects our body from invading foreign substances. In the early stage of development, 
they migrate through the lymphoid tissues and thymus, and acquire the self-recognition 
property. Therefore they are capable of combating infections without destroying our own 
body cells (68). Endothelial cells respond to the inflammatory signal by exposing new 
receptors and by immobilizing the immune cells. Leukocytes translocate to the affected 
tissue eventually and exert their immune function. Other antigen- presenting cells like 
macrophages and dendritic cells carry the pathogens to lymph nodes and instruct the B- 
or T-lymphocytes to fight against the infection. However the efficient migration of 
immune cells is very critical for providing immune protection to our body. 
 
 
Pathophysiology 
 
Cell migration is a crucial process in the development and maintenance of 
multicellular organisms. Embryonic development, wound healing and immune responses, 
all require the finely tuned cell migration. Erroneous cell migration leads to delayed 
wound healing, vascular disease, tumor formation and metastasis. Induction of abnormal 
migratory signal leads to catastrophic pathological conditions by migration of wrong cells 
at the wrong place. Interestingly the major problem associated with cell-based therapy is 
defective migration. 
 
Defects in the regulation of several migration related proteins result in embryonic 
lethality, malformed embryos or congenital abnormalities due to the disorganized and 
inappropriate migration of the component cells. On the other hand up regulation of those 
proteins are implicated in several chronic inflammations. For example in asthma, the 
constant presence of leukocytes leads to chronic airway inflammation in response to 
inhaled allergens which in turn causes hyper reactivity and severe tissue damage. In 
autoimmune disorders like rheumatoid arthritis, the continuous migration of 
inflammatory cells to the specific compartments and destruction of the tissues lead to 
severe joint pain and impaired limb function. 
 
During the process of metastasis cancer cells migrate from the initial site of tumor 
to distal organs where they continue to proliferate and form secondary tumor mass. The 
metastatic tumor cells exhibit an invasive phenotype with loss of cell- cell interaction and 
increased cell motility. Several cytokine and growth factors are up regulated in those 
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highly motile cancer cells. Finally the hyper proliferation and enhanced migration of 
vascular smooth muscle cells leads to atherosclerosis by progressive thickening of blood 
vessels. The vascular injury triggers inflammatory signal for leukocyte recruitment and 
consequent fibrous plaque (69). 
 
Taken together the regulation of cell migration is very important for the efficient 
treatment of many pathological conditions like cancer, angiogenesis and autoimmune 
disorders, multiple sclerosis, psoriasis and Crohn’s disease, all of which exhibit defective 
migratory components (70). Pathological conditions like non-healing ulcers often 
associate with abundant neutrophil infiltration, high concentration of reactive oxygen 
species and destructive enzymes and therefore delayed healing. New strategies to treat all 
those pathological conditions require a comprehensive understanding of all the complex 
biological processes that dynamically regulate cell migration. 
 
 
Regulation of Cell Migration 
 
From simple unicellular organism to complex multi cellular mammals, all 
requires cell migration as a fundamental process. In unicellular organisms the 
requirement for cell migration is restricted to food searching and mating (71). The 
specialization and complexity of multicellular organisms exploit the migration process 
for tissue organization, organ-development and homeostasis (50,52). 
 
 
Component process of cell migration 
 
As a highly integrated molecular event, cell migration is actually conceptualized 
as a cyclic process (72). The oscillatory cycles of membrane extension and retraction at 
cell front regulate the velocity and direction of cell migration. Steps involved in cell 
migration process are distinctly visible in slow moving cells like fibroblasts but are not as 
obvious in fast moving cells like neutrophils (50). In addition, depending on the 
migratory environment diverse molecular machineries can uniquely regulate the mode of 
migration. However both fibroblastic and amoeboid motility share some common 
features where they get polarize to extend the protrusion in the direction of migration. 
Figure 2-1 is illustrating the polarization of a migrating fibroblast. 
 
 
Protrusion formation. The de novo formation of membrane extension in the 
direction of cell migration is called protrusions. Protrusions consist of three major 
components-1) Formation of extension at the cell front by expansion of cell membrane, 
2) Stabilization of the extension by cytoskeletons and 3) formation of new adhesions with 
the substrum which provide the necessary traction force for the cell movement (51,52). 
 
Actin polymerization is the driving force for protrusion formation. Depending on 
the actin filaments organization; the protrusions can be classified into two groups- 
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Figure 2-1. Polarization of migrating fibroblast 
 
The illustration showed organization of actin cytoskeleton and microtubules, the 
protrusion and adhesion formation at cell front and rear, the reorientation of Golgi 
apparatus and microtubules -organizing center (MTOC) towards the leading edge in a 
migrating fibroblast. 
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1) Lamellipodium- a flat protrusion formed by the branched dendritic network of 
actin filaments (50). 
 
2) Filopodium- a spike like protrusion formed by long, parallel bundles of actin 
filaments (73). 
 
The primary purpose of filopodia is to sense and explore the local environment 
whereas with a broad and flat structure, lamellipodia are able to push a wide section of 
plasma membrane in the direction of cell migration. Two major types of protein regulate 
the actin nucleation in the protrusions- Apr 2/3 complex, and the formins mDia1 and 2 
(49,73). Apr2/3 binds to the sides or tips of pre-existing actin filaments and induces the 
formation of new actin filaments from the pointed end and at 70
o
 angle (73). 
 
During migration the WASP/WAVE family members get activated at the cell 
membrane by Rac GTPase and induce the localized activation of Apr 2/3. Cdc42 
phosphorylation can also regulate Apr 2/3 via WASP/WAVE. In contrast to Apr 2/3, 
formins bind to the barbed end and induce the linear extension of the existing actin 
filament for stabilizing the filopodia. By filament treadmilling mechanism actin filaments 
elongate at their barbed ends while releasing actin monomer from their pointed ends. As 
a result long and unbranched filaments bundles are formed rather that the branched 
nucleation in the filopodia. 
 
Ena/VASP proteins predominantly express at the tip of filopodia and antagonize 
both capping and branching. Hence VASP promotes elongation of actin filaments. Small 
GTPase including RhoA and Cdc42 can regulate formins and filopodia formations. 
Profilin promotes the actin polymerization in G-actin bound state via interaction with 
formins and regulates Ena/VASP mediated actin polymerization as an anti-capping agent 
(49,74,75). Actin filament severing proteins like ADF/cofilin generate actin monomer by 
disassembling the older filaments and by promoting dissociation from the pointed end to 
facilitate the actin polymerization. In contrast the capping proteins like gelsolin restrict 
the new filament growth near the plasma membrane (76-78). However the unbending of 
the elongated actin filament against the leading edge, provides the driving force for the 
extension of membrane protrusions (79). 
 
Rho GTPases play pivotal roles in adhesion and protrusion formations (80,81). 
They are active at GTP bound state and capable of interacting with downstream targets. 
GEFs can activate them whereas GAPs cause their inactivation. Among the Rho 
GTPases, Rac, Cdc42 and RhoA are required for lamellipodia, filopodia and stress fiber 
formation respectively. They are also regulated by WASP/WAVE proteins and thus a 
feedback loop controls the Rac/Cdc42 mediated actin polymerization (72). Apart from 
the Rho GTPases, Src family kinases and phosphoinositides are also involved in 
protrusion formation (77). 
 
 
Adhesion dynamics. Cell makes adhesions with the substrum during gliding by 
adhesive molecular interaction. The assembly and disassembly of the adhesions 
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dynamically regulate cell migration in response to an external cue. New adhesions grow 
in size and intensity in a temporal wave and persist until they reach the cell rear. Thus 
they facilitate the cell migration over them (82,83). Though more than 150 protein 
molecules are involved in adhesion formation, integrins are playing a major part is this 
aspect. Integrins are heterodimeric receptors that consist of α and β chain with large 
ligand binding and short cytoplasmic domains (84). They bind to several extracellular 
matrix ligand and regulate cytoskeleton organization and therefore protrusion formation 
by initiating intracellular signaling like tyrosine phosphorylation, activation of small 
GTPases, synthesis of phospholipids and adhesion stabilization. 
 
Integrins can be activated by proteins like talin, vinculin, α-actinin, small 
GTPases and PKC. They are preferentially localized to the leading edge of a migrating 
cell where new adhesions form. The phosphorylation of integrins disrupts the interaction 
between integrin and adaptor protein paxillin resulting in release of paxillin for 
stabilizing the lamellipodia (50,85,86). The large integrin mediated adhesion clusters are 
found mostly in the focal adhesions of slow or non-migrating cells and involve in Rho 
and myosin induced contractility. Rac and Cdc42 play important roles in formation of 
focal complexes that mediate cells attachment to the ECM (50). 
 
 
Cell polarization. This is the keystone for directional migration. A set of 
interlinked feedback loops involving Rho family of GTPases, phosphoinositides 3- 
kinases (PI3Ks), integrins, microtubules and vesicular transport help in establishing 
differential molecular processes at the front and back of a migrating cell (80). Not only 
the actin mediated protrusion formation or the trailing edge retraction, but also the 
reorientation of Golgi apparatus and the microtubules -organizing center (MTOC) toward 
the leading edge, define the cell polarity. 
 
The master regulator of cell polarity, Cdc42, regulates the MTOC and Golgi 
positioning through Par proteins and atypical PKC-dependent phosphorylation of dynein-
dynactin complex, and restricts the formation of lamellipodia at the cell front. It is also 
involved in myosin dependent nuclear repositioning (80,87). Proper MOTC orientation is 
essential for segregated microtubule growth in the lamella and restricted delivery of 
Golgi derived vesicles to the leading edge to provide the membrane and necessary 
proteins for forward protrusions (88,89). 
 
In response to a shallow gradient of chemo-attractants, PIP3, PI(3,4)P2 get 
polarized rapidly and the phosphatase PTEN remove them from cell sides and rear. These 
processes are involved in localizing Cdc42 activation at cell front. Both inhibition and 
global activation of Cdc42 lead to a disrupted directional migration (90). 
 
On the other hand, Rac gets activated at the leading edge by PI3K mediated local 
activation of Rac exchange factors. Rac can itself activate those PI3Ks and thus can form 
a positive feedback loop at the leading edge. To induce directional migration Rac and 
microtubules can activate each other. Integrin engagement plays role in activating and 
membrane targeting Rac as well (88,91). The localized activations of PI3Ks, Cdc42 and 
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Rac at the cell front are not enough for establishing cell polarity. The restricted activation 
of Rho at the trailing edge is important for stabilizing microtubules and promoting the 
adhesion turnover (88). 
 
At the leading edge Rac activation suppresses Rho activation whereas at the sides 
and rear of cells Rac activity gets suppressed by activation of Rho. This mutual 
antagonistic activity is important for polarization of migrating cell (50). 
 
 
Retraction of trailing edge. This is the final step of cell migration where cells 
can actually move forward by detaching the adhesions at the rear. Tractional forces are 
generated by integrin mediated interactions of intracellular cytoskeleton and ECM. 
Migrating cells exert traction to the substrum during trailing edge retraction. The cell 
attachments regulate the speed of migration in a biphasic manner and is determined by 
the adhesive ligand on substrum, number of adhesion receptors on the cell surface and the 
affinity of receptors for the ligands (51). 
 
Interaction of Myosin II with actin cytoskeleton induces the tractional force at the 
adhesions. Myosin II activity is dynamically regulated by myosin light chain (MLC) 
phosphorylation by MLC kinases (MLCK), Rho kinases (ROCK) and MLC 
phosphatases. In contrast to ROCK which is regulated by Rho GTP, MLCK is regulated 
by intracellular calcium and phosphorylation (50,92). 
 
Both at the front and the rear of a migrating cell, the disassembly of adhesion can 
be observed for serving different purposes like protrusion formation and tail retraction 
respectively. Tyrosine kinase like FAK and Src plays important roles in adhesion 
turnover by regulating Rac specific GEFs and by activating mitogen activated protein 
kinase MAPK/ERK at the leading edge (93,94). 
 
New adhesion formation and turnover of old adhesion mediate the cell 
translocation. The adhesions at the rear tether the cell strongly to the substrum and thus a 
long tail of trailing edge is formed during migration of slow moving cells. This tension 
can break the linkage between integrins and actin cytoskeleton and therefore integrin is 
left behind on the substrum after the rest of the cell moves forward. 
 
Myosin II and its activator PAK are important for this retraction event and the 
deficiency of any of those proteins results in an impaired retraction and formation of 
multiple pseudopods (50,51). 
 
The tractional force induced stress elevates the intracellular calcium levels and 
this calcium is implicated in adhesion disassembly by activating the focal adhesion 
cleaving proteins like calcium regulated phosphatase calcineurin and calcium activated 
protease calpain (95,96). However the release of adhesion at the cell rear is coupled to the 
protrusion formation at the cell front and they dynamically regulate directional cell 
migration. 
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Cyclic nucleotide-dependent regulation of cell migration 
 
Cyclic nucleotides play important roles in the signaling pathways at various 
stages of the cell migration process, either directly or by activating their corresponding 
kinases. It has long been known that cyclic nucleotides and their downstream signaling 
molecules are involved in regulation of different types of cell migration (97,98). Earlier 
some studies showed that cAMP and cGMP have opposing effect on cell migration; and, 
according to the “Yin-Yang” hypothesis, cGMP stimulates whereas cAMP inhibits cell 
migration (98). But the actual role of cAMP and cGMP in cell migration remains 
controversial. The complex and equivocal effects of cAMP and cGMP on cell migration 
ensure the importance of a tightly regulated and balanced intracellular cyclic nucleotide 
levels for fine-tuned cell migration. 
 
 
cAMP and cell migration. Studies in past few decades have revealed that cAMP 
and cAMP-dependent protein kinase A (PKA) are important for localized cell protrusion 
formation and efficient cell migration (99-101). PKA plays important role in F actin 
arrangement by phosphorylating Hsp27 (102) The leading edge of a migrating cell 
accumulates more PKA compared to the rest of the cell body, and this compartmentalized 
activation of PKA is an important early step in directional cell migration. 
 
In polarized cell, the gradient of PKA activity is maintained by a specific A-
kinase anchoring protein AKAP-Lbc (101). PKA has been found to both facilitate and 
inhibit actin cytoskeleton rearrangements and cell migration because of the diversity of 
the substrates for PKA. 
 
But inhibition of PKA activity as well as interference with PKA anchoring causes 
a defective pseudopod formation and an attenuated cell migration possibly in a Rac 
GTPase-dependent fashion (103). In addition PKA can increase the epithelial cell 
migration by reducing Rho activity and inducing focal adhesion turn over (104) 
Paradoxically elevation of cAMP levels is reported to inhibit lamellipodia formation in 
mouse embryonic fibroblast cells (MEFs) and mouse breast tumor cells by acting 
downstream of small GTPase Rac (105). More over PKA activity establishes an 
oscillatory cycles of membrane protrusion and retraction by phosphorylating RhoA and 
increasing the interaction of RhoA with GDI (105). 
 
 
cGMP and cell migration. The molecular mechanism of cGMP mediated 
regulation of cell migration is still poorly understood. Recent studies showed that cGMP-
dependent protein kinase (PKG) activation attenuates phosphorylation of the actin-
severing protein cofilin (Ser3) and therefore induces the formation of actin monomer for 
polymerization of new filaments in the cell protrusions (39). Conversely adhesion and 
migration of vascular smooth muscle cells (VSMC) increase in hypoxic conditions, due 
to down regulation of PKG (106). 
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Cells that overexpress VASP, a major substrate of PKG, have a higher protrusion 
formation rate but a significantly slower cell migration rate (75). Phosphorylation of 
VASP by PKG can relieve this overall negative effect on cell migration. The Rac GTPase 
and PAK-dependent feedback mechanism plays pivotal role for maintaining the repetitive 
behavior of cell migration. Additionally cGMP stimulates the activity of Rac and PAK 
and thus facilitates the process of cell migration. 
 
PKA and PKG both can exert differential effects on the contractility and tension 
transmission in migrating cells by phosphorylation mediated activation of both myosin 
light chain kinase and myosin phosphatase (39,49). Together cyclic nucleotides and 
cyclic nucleotide-dependent kinases are involved in and regulate various signaling events 
that compose cell migration. 
 
Highly regulated PKA and PKG activities and therefore a tightly balanced 
intracellular cyclic nucleotide levels are important for proper cell migration (17). 
 
 
Hypothesis 
 
Roles of cyclic nucleotides and cyclic nucleotide-dependent signaling molecules 
in regulating several signaling events including cell migration have long been known. 
However, the new and revolutionary concept is that it is not just the absence or presence 
of cyclic nucleotides, but a highly coordinated balance between these molecules regulates 
cell migration. 
 
Multi-drug resistance protein 4 (MRP4) is a member of the large family of ATP 
binding cassette (ABC) transporter proteins. It is localized to the plasma membrane and 
functions as a nucleotide efflux transporter and thus plays a pivotal role in the regulation 
of intracellular cyclic nucleotide dynamics. 
 
In our study we used MRP4 expressing fibroblast cells and MRP4 knockout mice 
as model systems and wound healing assays as the experimental system to explore this 
unique and emerging concept. The unifying hypothesis of my study is that- 
 
 Inhibition of MRP4 increases the intracellular cyclic nucleotide (e.g. cAMP and 
cGMP) levels in fibroblasts. 
 
 This altered cyclic nucleotide levels may have a role in regulating fibroblast 
migration. 
 
 MRP4 interacting proteins may play some key roles in the regulation of fibroblast 
migration. 
 
Schematics of the hypothesis are shown in Figure 2-2. 
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Figure 2-2. Schematics of the hypothesis 
 
The illustration showed the molecular mechanism of MRP4 dependent cell migration and 
the role of cyclic nucleotides as effector molecules. 
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Specific Aims 
 
The specific aims of my study are the following – 
 
 
Part 1: To determine the role of MRP4 in fibroblast migration 
 
 Subaim 1: To determine the expression and function of MRP4 in fibroblast cells. 
 
 Subaim 2: To study the role of MRP4 in regulating the intracellular cyclic 
nucleotide dynamics in fibroblasts. 
 
 Subaim 3: To investigate the effect of cyclic nucleotides on cell migration. 
 
 
Part 2: To investigate the importance of MRP4-interactome in fibroblast migration 
 
 Subaim 1: To identify the MRP4-interactome. 
 
 Subaim 2: To determine the effect of MRP4 containing macromolecular 
complexes on cell migration. 
 
 Subaim 3: To identify the downstream targets of MRP4 that regulate cell 
migration. 
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CHAPTER 3.    MATERIAL AND METHODS* 
 
 
Reagents 
 
MRP4 inhibitor MK571 was obtained from Cayman Chemical (Ann Arbor, MI). 
Forskolin was obtained from Tocris (Ellisville, MO). IBMX, Latrunculin B (Lat B), cpt-
cAMP, and cpt-cGMP were purchased from Sigma-Aldrich (St. Louis, MO). Zaprinast 
and PKA inhibitor H 89, 2HCl were purchased from Enzo Life Sciences (Farmingdale, 
NY). 
 
 
Cell Culture and Transfections 
 
MEF cells and NIH 3T3 cells were cultured in DMEM media and MRP4 
overexpressed and HEK 293 cells were grown in DMEM F-12  media (Invitrogen; 
Carlsbad, CA) containing 10% FBS and 1% penicillin/streptomycin and maintained in 
5% CO2 incubator at 37
o
C. 
 
Mrp4
+/+
 and Mrp4
-/-
 primary MEFs were transfected with 1 µg of total SV40 
genomic DNA using Lipofectamine LTX (Invitrogen). Next day the transfected cells 
were serially diluted (1000 to 10 cells per well) and plated in 96-well plates. SV40 
immortalized clones were selected from the lower dilutions wells (17). 
 
Lipofectamine 2000 (Invitrogen) was used for all transient transfections according 
to the manufacturer’s instructions, and MRP4-overexpressing cell lines were generated 
by using lentivirus vector and selected by puromycin (2 µg/ml). 
 
 
Wound Healing Assay  
 
According to the previously described method cell migration was measured using 
in vitro wound healing assay. Wounds were made in the confluent monolayers of 
fibroblast cells by scraping with a pipette tip across the monolayer. Cells were washed 
thoroughly with PBS and incubated with warm media (107). Images of were taken with 
100X magnification at the initial time of wounding and then at 6 h or 10 h post-
wounding. A cooled electron microscope (EM)-CCD camera (Hamamatsu; Bridgewater; 
Denver, CO) was used for capturing the images. The cell migration was represented as a 
percentage of initial wound length after analyzing by Image J software. 
 
                                                 
 
*
 Adapted with permission. This research was originally published in The Journal of Biological Chemistry. 
Sinha, C., Ren, A., Arora, K., Moon, C. S., Yarlagadda, S., Zhang, W., Cheepala, S. B., Schuetz, J. D., and 
Naren, A. P. Multi-drug resistance protein 4 (MRP4)-mediated regulation of fibroblast cell migration 
reflects a dichotomous role of intracellular cyclic nucleotides, (2013) J Biol Chem, 288, 3786-3794. © the 
American Society for Biochemistry and Molecular Biology. 
 24 
Animals 
 
Mrp4
-/- 
and Mrp4
+/+
 (C57BL/6) mice were provided by Dr. John Schuetz at St. 
Jude Children's Research Hospital, Memphis, TN, USA (6,17). 
 
 
Skin Explant Outgrowth Assay 
 
Mice were euthanized by CO2 inhalation and cervical dislocation. Full thickness 
dorsal skin biopsies (5 mm) were excised from 8 weeks old Mrp4
-/-
 and Mrp4
+/+
 mice 
after removing the hair. The skin patches were fixed in fibronectin-coated 6-well plates, 
placing the dermal side down. The skin explants were cultured in DMEM media with 
10% FBS and 1% penicillin/streptomycin and maintained in 5% CO2 incubator at 37
o
C 
for 5 days (108,109). Representative images of the cellular outgrowth from each explant 
were taken at 100X magnification. The proximal distance of cellular migration from the 
edges of the skin patches was measured by Image J software. 
 
 
High Content Microscopy 
 
Fibroblast cells were grown in a fibronectin-coated 96-well Essen BioScience 
Image-Lock microplate in a standard CO2 incubator for 24 hours. Precise wounds were 
made by the 96-pin Wound-Maker provided with the IncuCyte
TM
. After that, cells were 
washed thoroughly with PBS to remove the detached cells. Microplates were then placed 
in the IncuCyte
TM
 with appropriate media. At 1-h interval, the wound images were 
automatically captured by IncuCyte
TM
 (Essen Bioscience) from the incubator. The 
relative wound density (RWD)  kinetics were analyzed by IncuCyte
TM
 software (110). 
 
 
Crude-Membrane Isolation 
 
Cells were washed with ice cold PBS for two times and then were harvested with 
hypotonic buffer (10mM HEPES, 1mM EDTA, pH-7.2 and protease inhibitors: 1 mM 
phenylmethylsulfonyl fluoride (PMSF), 1 μg/ml pepstatin A, 1 μg/ml leupeptin, and 1 
μg/ml aprotinin). Then they were homogenized in hand held dounce (1ml) homogenizer 
(20 strokes, three times with1 min interval) on the ice followed by centrifugation at 3000 
rpm at 4
o
C for 10 min. The supernatant was collected as post nuclear supernatant (PNS). 
Then the PNS was ultra-centrifuged at 35000 rpm for 1h at 4
o
C using Ti70.1 rotor 
(Beckman Coulter, USA). After centrifugation the supernatant was collected as 
cytoplasm and the crude membrane pellet was resuspended in hypotonic buffer. The 
membrane suspension was sonicated in glass tube for 20sec for three times at 30 sec 
interval to get a uniform suspension (111).Total protein concentrations were measured for 
PNS, cytosol and membrane fraction using Bradford method and equal amounts of 
proteins for each fraction were used for immunoblotting. 
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Immunoblotting 
 
For western blot, the cells were lysed in lysis buffer (1× PBS, containing 0.2% 
Triton X-100 and protease inhibitors: 1 mM phenylmethylsulfonyl fluoride (PMSF), 1 
μg/ml pepstatin A, 1 μg/ml leupeptin, and 1 μg/ml aprotinin). Cell lysate was centrifuged 
at 16,000 × g for 10 min at 4°C. The clear supernatant was collected and mixed with 5× 
Laemmli sample buffer (containing 2.5% β-mercaptoethanol), denatured, subjected to 
SDS-PAGE on 4–15% gel (Bio-Rad; Hercules, CA) and transferred to PVDF membrane. 
The membrane was blocked with 5% non-fat milk and then was incubated with specific 
primary antibodies. 
 
We used anti-MRP4 antibody (rabbit polyclonal antibody) for MRP4 detection. 
Anti-beta actin antibody (mouse) was purchased from Sigma-Aldrich Co. (St. Louis, 
MO). VASP and phospho VASP (Ser157) antibodies were purchased from Cell Signaling 
Technology (Danvers, MA) and PKA RIIα antibody was obtained from Transduction 
Laboratories (Lexington, KY). 
 
The chemiluminescence from the protein bands was detected using ECL
TM
 
Western blotting detection reagents from GE Healthcare (Buckinghamshire, UK). 50µg 
of total protein was loaded per lane (6,17). 
 
 
Functional Assay for MRP4 
 
 
Radioactive assay 
 
Cells were plated at 500,000 cells/well in a 6 well plate with 2mls of DMEM 
complete media. After two days the media were removed and cells were washed one time 
with warm HBSS. Then10 µM of [3H] Bis (pom) PMEA or [3H] PMEA was added to 
cells in DMEM media without any FBS. Cells were incubated for 24 hours and then the 
media were aspirated. 
 
For determining the whole cell uptake, cells were washed two times with ice cold 
PBS to terminate the cellular uptake and lysed in 1 ml of 0.5N NaOH with continuous 
agitation for 10 minutes. 500µl of lysate were neutralized with 300 ml of 0.1 M HCl. For 
measuring the efflux rate, media was collected at 30 min interval for 1 hour. Then 4.5 ml 
of scintillation fluid and 500µl of neutralized lysate or media were added to the 
scintillation vials. The radioactivities of the samples were measured by Tri-Carb Liquid 
Scintillation Counter (Perkin Elmer, Waltham, MA) (112-114). 
 
 
Fluorescent assay 
 
Approximately 24 hours after seeding, media were removed and cells were 
washed twice with HBSS. The cells were then incubated with HBSS for equilibration. 
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After 15 minute of equilibration period, HBSS was aspirated from the dish and the 
experiment was initiated by the administration of solutions of 1.25 μM 8-FcA in presence 
or absence of MRP4 inhibitor MK571. 
 
Cellular uptake of 8-FcA was terminated by aspirating the substrate solution after 
two hours of incubation and cells were washed three times with ice cold PBS. The cells 
were extracted then using 200µl of a 50:50 solution of Methanol: Tris-EDTA (10 mM, 1 
mM), pH 8.0 for approximately 10 minutes. The buffered extraction solution helps in 
minimizing effect of pH on 8-FcA fluorescence. 50µl of the extract was transferred to a 
black OptiPlate-96 for the fluorescence measurements (λex = 485 nm/λem = 535 nm) 
using Fluostar Omega (BMG Labtech) microplate reader (115,116). 
 
 
Fluorescence Resonance Energy Transfer Microscopy 
 
CFP-EPAC-YFP was a generous gift from Dr. Kees Jalink (Division of Cell 
Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The 
Netherlands), Cygnet 2.1 was a generous gift from Dr. Wolfgang R Dostmann 
(Department of Pharmacology, University of Vermont, Burlington, VT 05405, USA), and 
the CFP tagged regulatory and YFP tagged catalytic subunit of PKA were a generous gift 
from Dr. Manuela Zaccolo (Department Of Physiology, Anatomy & Genetics, University 
of Oxford, UK) (117). Transfected cells were grown in 35-mm glass-bottomed dishes 
(MatTek) for 24–48 h (117,118). 
 
After washing with HBSS, cells were mounted on an Olympus microscopy 
system for FRET imaging. Using the cooled CCD camera Hamamatsu ORCA285 
(Hamamatsu, Japan) mounted on the Olympus microscope IX51 (U-Plan Fluorite 60 × 
1.25 NA oil-immersion objective) images were recorded. The system was controlled by 
SlideBook 4.1 software (Intelligent Imaging Innovations; Denver, CO) and ratio modules 
were used to obtain and analyze the images. A 300W Xenon lamp attenuated with a ND 
filter with 50% light transmission provided the excitation light. Images were taken by a 
JP4 CFP/YFP filter set (Chroma; Brattleboro, VT), including a 430/25-nm excitation 
filter, a double dichroic beam splitter, and two emission filters (470/30-nm for CFP and 
535/30-nm for FRET) alternated with a filter-changer Lambda 10–3 (Sutter Instruments; 
Novato, CA). 
 
With 100 ms exposure time, time-lapse images were taken at 1-min intervals. 
Multiple regions of interest (ROIs) were selected on the cell after background subtraction 
for quantitative data analysis (4–6 cells per condition). At different time points the 
emission ratio images (CFP/FRET) were obtained as described previously. The 
representative pseudo color images at 60X magnification were shown to indicate the 
changes in the ratio of CFP to FRET intensity (118,119). 
 
Membrane targeted pmAKAR3 and pmAKAR3-TA sensors were generous gifts 
from Dr. Jin Zhang, (Department of Pharmacology and Molecular Sciences, The Johns 
Hopkins University School of Medicine, Baltimore, MD 21205, USA). These sensors 
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were used for monitoring PKA activity. PKA mediated phosphorylation increases the 
FRET between the CFP and YFP tag. Cells transfected with pm AKAR3 sensor were 
subjected to FRET measurement after background subtraction. FRET was normalized 
with donor CFP intensity (FRET/CFP) to obtain the normalized corrected FRET (N-
FRET) which was represented as an index of PKA activity (120,121). 
 
To confirm the specificity of this PKA sensor, we used the mutant PKA sensor 
pmAKAR3-TA. This point mutant cannot be phosphorylated by PKA as it contains a 
threonine-to-alanine mutation in the PKA substrate region. In basal condition it gives a 
lower FRET value compare to pmAKAR3 and is not responsive to PKA activation. 
 
 
Cyclic AMP and cGMP Measurement 
 
Quantification of cAMP and cGMP were performed by specific competitive 
immunoassay according to the manufacturer's instructions (Enzo Life Sciences, complete 
ELISA kit for cAMP and cGMP). In brief cells were lysed in 0.1M HCl, and neutralized 
with neutralizing agent. Those lysate were used for subsequent measurement of cyclic 
nucleotides using the cAMP or cGMP specific rabbit polyclonal antibody and Goat anti‐
Rabbit IgG coated microtiter plates. As the concentration of cAMP is at least 10 fold 
higher than that of cGMP inside the cells, the acetylation reagent (acetic anhydride to 
triethylamine 1:2) was used during intracellular cGMP measurement for increasing the 
assay sensitivity by 10 fold (17). 
 
The Fluostar Omega (BMG Labtech) microplate reader was used to measure the 
optical density at 405 nm. Standards, supplied with the kit, were run in parallel for the 
quantitation of intracellular cyclic nucleotides. 
 
 
Purification of HA-MRP4  
 
HEK-293 cells, stably overexpressing hemagglutinin (HA)-MRP4 were seeded on 
ten 100 mm dishes, and grown until completely confluent. The cells were then washed 
twice with PBS and lysed with PBS containing 0.2% Triton-X-100 and 
phenylmethylsulfonyl fluoride 1 mM, pepstatin-A 1 μg/ml, leupeptin 1 μg/ml, aprotinin 1 
μg/ml. After lysis, the cell lysate was mixed for 15 min at 4°C and centrifuged at 13,000 
rpm for 10 min. 
 
HA-MRP4 were immunoprecipitated from the supernatant using α-HA beads for 
overnight at 4°C. The beads were washed several times by centrifugation at 3,000 rpm for 
1 min. The bead bound MRP4 was eluted with 100 mM glycine (pH 2.2) and neutralized 
with 150 mM tris (pH 8.8). The eluted MRP4 containing macromolecular complexes 
were run by SDS-PAGE on 4-15% gel (Bio-Rad, Hercules, CA) and then were visualized 
with Gel Code Blue or immunoblotted with rabbit polyclonal MRP4 antibody. 
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The MRP4 containing macromolecular complexes were subjected to mass 
spectrum analysis for identifying the MRP4 interacting partners. 
 
 
Cross Linking of IgG for Endogenous Immunoprecipitation 
 
50µl of protein A/G (Santa Cruz SC2003) were taken into spin cup (Pierce 69700) 
and washed twice with 200 ul PBS by centrifugation at 3,300 rpm/1,000 for 1 min). 5-
10µg of IgG was added to the protein A/G in 100µl of PBS and mixed for 60 min at room 
temperature. The protein A/G beads were washed two times with 400µl of PBS and 4.5µl 
of freshly made 10 mM DSS stock with 94.5µl PBS were added to beads. The beads were 
cross-linked with the antibody for 60 min at room temperature. After crosslinking the 
beads were washed with 50µl of glycine elution buffer (Pierce 21004) for one time 
followed by with 100µl of glycine elution buffer for two times. 
 
The beads were resuspended and stored in PBS-0.2% TX100 at 4°C. These beads 
were used for immunoprecipitations of endogenous MRP4 from MEFs. 
 
 
Co-Immunoprecipitation 
 
Mrp4
-/-
 and Mrp4
+/+
 MEFs were lysed using lysis buffer-1X PBS, containing 
0.2% Triton-X-100 and protease inhibitors. The supernatant was subjected to 
immunoprecipitation using MRP4 rabbit polyclonal antibody conjugated protein A/G for 
overnight at 4°C. The beads were washed several times by centrifugation at 3,000 rpm for 
1 min and the MRP4 containing macromolecular complexes were eluted with 100 mM 
glycine (pH 2.2) and neutralized with 150 mM Tris (pH 8.8). The eluted proteins were 
mixed with the sample buffer (5X; containing 1% β-mercaptoethanol), denatured, 
subjected to SDS-PAGE, transferred to PVDF membrane, and immunoblotted using goat 
polyclonal anti-MRP4 antibody and anti-beta actin antibody (mouse). 
 
 
Immunofluorescence 
 
Cells were washed three times with PBS and fixed with 4% formaldehyde. After 
washing three times with PBS, cells were permeabilized with 0.2% Triton X-100. After 
washing three times with PBS, cells were blocked with 2.5% normal horse serum for 
overnight at 4
o
C. Next day, cells were washed three times with PBST (PBS: Tween 80, 
1:2000) for 5 minutes each. For immunostaining, the samples were incubated overnight 
with respective primary antibodies and then washed three times with PBST for 5 minutes 
each. Cells were then incubated with secondary Phalloidin Alexa Fluor 488 or anti Rabbit 
Alexa Fluor 568 (Molecular Probes, Invitrogen) for 1 hour and mounted in DAPI 
containing Vectashield, obtained from Vector (Burlingame, CA). Fluorescent images 
were taken using a NikonA1R-A1 confocal microscope system (121,122). 
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Protein Kinase A Activity Assay 
 
Cells were lysed in Tris-based lysis buffer with PMSF 1 mM, pepstatin-A, 1 
μg/ml leupeptin 1 μg/ml, aprotinin 1 μg/ml and 10 mM activated orthovanadate 
(phosphatase inhibitor) and used for PKA activity assay using DetectX, PKA activity kit, 
obtained from Arbor Assays (Ann Arbor, MI). 
 
In brief, the lysate containing PKA phosphorylated the immobilized PKA 
substrate on the microtiter plate in presence of ATP. Antibody specific for phospho-PKA 
substrate recognized the immobilized phosphorylated substrate and got detected by 
peroxidase conjugated anti rabbit IgG. The Fluostar Omega (BMG Labtech) microplate 
reader was used to measure the optical density at 450 nm. Standards, supplied with the kit 
were run in parallel for the quantitation of total PKA activity. 
 
 
Single Particle Tracking 
 
NIH3T3 cells stably expressing HA-MRP4 were grown on 35-mm glass-bottom 
dishes (MatTek). Cells were washed with PBS containing 6 mM glucose and 1 mM 
sodium pyruvate (PBS/Glu/NaPyr) for two times. PBS/Glu/NaPyr containing 4% BSA 
was used for blocking the washed cells for 10 min. After blocking cells were incubated 
with biotin conjugated α-HA antibody (1 μg/ml, Sigma) for 15 min, washed five times 
with the HBSS followed by an incubation with streptavidin-conjugated Qdot-655 (0.1 
nM, Invitrogen) for 2 min in absence of light. 
 
After that cells were washed extensively for eight times, and mounted 
immediately on the Olympus inverted microscope (IX51). The images were captured 
using Hamamatsu EM-CCD camera at 1–3 frames per second for 1–3 min with 50-ms 
exposure time, 100× oil-immersion objective (NA 1.40), xenon (300-W lamp) light 
source, and SlideBook 4.2 software. Qdot 655-A Bright-Line high brightness and contrast 
single band filter set (Semrock, Rochester, NY) was used for collecting data. Single-
particle tracking (SPT) was monitored by the particle-tracking module of SlideBook 4.2 
software. The software generated trajectories for single Qdot and calculated the mean 
square displacement (MSD) and diffusion coefficient (D). Data obtained from five to ten 
cells were used for plotting histograms of the diffusion coefficient (121). 
 
To monitor changes in lateral diffusion of MRP4 in fibroblasts with cytoskeletal 
disruption, cells were pretreated with Lat B (1 μM, 30 min) or DMSO (as control), and 
they were also added to the buffer during the course of the experiment. 
 
 
Measurement of Protein Concentration 
 
Protein concentrations were measured by Bradford Assays using Bio-Rad protein 
assay dye. BSA was used as standard. Samples or standards were dissolved in 800µl of 
distilled water and then 200µl of dye was added. The absorbance was measured at 595nm 
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using spectrophotometer. Protein concentrations for each sample were calculated using 
BSA based standard curve. 
 
 
Ingenuity Pathway Analysis 
 
With the help of Ingenuity Pathway Analysis we assigned MRP4 as seed and the 
MRP4 interacting proteins as high confidence (HC) interactome (123,124). Then we 
checked the interconnectivity between those proteins in the context of cell migration, 
using the “shortest path” explorer which also includes the intermediate proteins involved 
in the pathway based on literature and experimental evidences. Subsequently we 
identified specific migration related signaling events that are regulated by certain nodes 
in the interactome network. 
 
 
Statistical Analysis 
 
The mean values of different groups were compared by two tailed student’s t-test 
and P values less than 0.05 were considered as significant. All the data were presented as 
mean ± SEM where n indicated the number of experiments. 
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CHAPTER 4.    RESULTS* 
 
 
Expression of MRP4 in Fibroblasts 
 
Multi-drug resistance protein 4 (MRP4/ABCC4) is a membrane protein that 
belongs to the C subfamily of ATP-binding cassette (ABC) transporters family. MRP4 
utilizes the energy of ATP hydrolysis to translocate the substrates across the membrane 
(3,7). MRP4 is found to be expressed predominantly on plasma membrane of various cell 
types in tissues with barrier functions like intestine, blood capillaries, brain, liver, 
placenta and kidney. We wanted to see the expression of MRP4 in MEF cells isolated 
from Mrp4
-/- 
and Mrp4
+/+
 mice. To show the membrane specific expression of MRP4, we 
isolated the post nuclear supernatant (PNS), cytoplasm and crude membrane fraction 
from the Mrp4
-/- 
and Mrp4
+/+
 MEFs. We loaded equal amount of protein (50 µg) for all 
different fractions and immune-probed for MRP4 using anti-MRP4 antibody (rabbit 
polyclonal antibody). As expected, we found that in Mrp4
+/+
 MEFs, MRP4 is present 
predominantly at the membrane fraction. Though the total PNS fraction also showed 
MRP4 expressions, the cytoplasm fraction did not exhibit any significant MRP4 
expression. However we did not find any MRP4 expression in the post nuclear 
supernatant (PNS), cytoplasm and membrane fractions of Mrp4
-/-
 MEFs (Figure 4-1). 
These data indicated that MRP4 is expressed in plasma membrane of the fibroblast cells. 
 
 
Function of MRP4 in Fibroblasts 
 
After confirming the membrane specific expression of MRP4, we tried to measure 
the function of MRP4 in fibroblasts cells using whole cell PMEA uptake and PMEA 
efflux assays. MRP4 was first identified as an efflux transporter of nucleoside based 
antiviral drugs in human T-lymphoid cell lines (7) and it has a very high affinity for 
PMEA (Km> 1000) (125). Therefore we used radiolabeled [3H] PMEA as MRP4 
substrate to monitor MRP4 activity. When we measured the whole cell [3H] PMEA 
uptake, we found that due to the absence of MRP4 mediated efflux process, Mrp4
-/-
 
MEFs accumulate significantly higher amount of PMEA inside the cell compare to 
Mrp4
+/+
 MEFs (Figure 4-2A).Similarly when we measured the PMEA efflux at different 
time points after incubating the cells with [3H] PMEA, we found that the absence of 
MRP4 significantly reduces the PMEA efflux rate in Mrp4
-/-
 MEFs compare to the 
Mrp4
+/+
 MEFs (Figure 4-2B). From these observations we confirmed that in fibroblast 
cells, MRP4 is predominantly expressed at the plasma membrane and functions as an 
endogenous efflux transporter. 
 
                                                 
 
*
 Adapted with permission. This research was originally published in The Journal of Biological Chemistry. 
Sinha, C., Ren, A., Arora, K., Moon, C. S., Yarlagadda, S., Zhang, W., Cheepala, S. B., Schuetz, J. D., and 
Naren, A. P. Multi-drug resistance protein 4 (MRP4)-mediated regulation of fibroblast cell migration 
reflects a dichotomous role of intracellular cyclic nucleotides, (2013) J Biol Chem, 288, 3786-3794. © the 
American Society for Biochemistry and Molecular Biology. 
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Figure 4-1. Expression of MRP4 in MEF cells 
 
The immunoblot data using anti-MRP4 antibody (rabbit polyclonal antibody) showed the 
expressions of MRP4 in post nuclear supernatant (PNS), cytosol (Cyto) and membrane 
(Mem) fractions of Mrp4
-/- 
and Mrp4
+/+
 MEFs. 
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Figure 4-2. Functional assay for MRP4 
 
MRP4 function was measured using [3H] PMEA as MRP4 substrate. (A) Bar graphs 
represented the whole cell PMEA uptakes for Mrp4
-/- 
and Mrp4
+/+
 MEFs. (B) Line 
graphs represented the PMEA efflux rates in Mrp4
-/- 
and Mrp4
+/+
 MEFs. All data 
represented at least three independent experiments (n=3). * indicated P <0.05. 
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MRP4 Deficient Mice Fibroblasts Migrate Rapidly and Heal Wounds Faster 
 
Cyclic nucleotides and cyclic nucleotide dependent kinases play important roles 
in different hallmark steps of cell migration (39,99). Among various endogenous 
substrates, MRP4 has higher affinity for cAMP and cGMP (3,21). Therefore MRP4 can 
regulate the intracellular cyclic nucleotide level and MRP4 deficient cells have altered 
cyclic nucleotides dynamics. These altered levels of cyclic nucleotide can lead to a 
modified cAMP/cGMP dependent signaling pathways including cell migration (23,126). 
Therefore we hypothesized that in absence of MRP4, fibroblast cells will exhibit an 
altered cyclic nucleotide dynamic and therefore a change in migration kinetics. To test 
the effect of MRP4 on cell migration we first performed the conventional in-vitro scratch 
wound assay. For our study we used two most commonly used fibroblasts, 1) mouse 
embryonic fibroblast cells (MEFs) and 2) NIH 3T3 cell line. We generated MEFs from 
wild type and Mrp4
-/-
 mice to confirm the specific effect of MRP4 on cell migration 
(127). 
 
Uniform wounds were made on the confluent monolayers of Mrp4
-/-
 and Mrp4
+/+ 
MEFs treated with DMSO or MRP4 inhibitor MK571 using pipet tip. Then cell 
migrations were monitored only for 6 hours to minimize the effect of cell proliferation. 
When we measured the total cell migration for 6 hours as a percentage of initial wound 
length using this conventional in-vitro wound healing assays, we found that Mrp4
-/-
 MEF 
cells migrate significantly faster compare to the wild type cells (Figure 4-3A). Similarly 
when we treated wild type MEFs with MRP4 inhibitor MK571, the cell migration rate 
significantly increased and they started migrating in a similar rate with Mrp4
-/-
 MEF cells 
(Figure 4-3A). These data indicated that inhibition of MRP4 can augment the fibroblast 
cell migration. When we checked the MRP4 expressions in those cells by immunoblot, 
we found that Mrp4
-/-
 MEFs have no MRP4 expression but both MK571 treated and 
untreated Mrp4
+/+ 
MEFs have similar MRP4 expressions (Figure 4-3B). These data 
indicated that MK571 antagonize MRP4 functions without affecting the expression and 
therefore the rate of fibroblasts migration is inversely related to MRP4 function. Notably 
all the cells had similar actin expressions. 
 
To further support the data obtained by the conventional in-vitro wound healing 
assays, we used high content microscopic technique to investigate the regulation of 
fibroblast migration by MRP4 in-vitro. The precise wounds were made in the confluent 
monolayer of MEFs isolated either from Mrp4
-/-
 or Mrp4
+/+
 mice by the wound maker 
and images were taken at 1hour interval for 18 hours using the IncuCyte
TM
 live cell 
imaging system. The Relative Wound Density (RDW) i.e. the spatial cell density inside 
the wound area relative to the spatial cell density outside the wound area, at every time 
point was measured. The RWD parameter is advantageous for being self-normalized to 
the changes in cell density due to cell proliferation. The kinetics of RDW for Mrp4
-/-
 and 
Mrp4
+/+
 MEFs were depicted in Figure 4-4. 
 
In agreement with our previous experiment the MRP4 deficient MEFs were found 
to have faster RDW kinetics than wild type MEFs. All these data indicated that MRP4 
has an inhibitory effect on MEFs migration. 
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Figure 4-3. MRP4 deficient fibroblasts migrate faster 
 
(A)The conventional wound healing assay was performed on the confluent monolayers of 
Mrp4
-/-
 or Mrp4
+/+
or MK571 treated Mrp4
+/+
 MEFs and images were taken at 0th and 
6th hour. The initial and final wound lengths were calculated and cell migrations were 
represented as a percentage of initial wound length in the bar graph. (B) The immune-
blots data showed the expression of MRP4 in Mrp4
-/-
, Mrp4
+/+
 and MK571 treated 
Mrp4
+/+
 MEFs. All data represented at least three independent experiments (n=3). 
* indicated P <0.05. 
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Figure 4-4. High content microscopy shows higher RWD kinetics for Mrp4 
-/-
 
fibroblasts 
 
Mrp4
-/-
 or Mrp4
+/+
 MEFs were grown on fibronectin-coated 96-well Essen BioScience 
ImageLock dishes and the wounds were made precisely using 96-pin Wound-Maker 
provided with the IncuCyte
TM
. The kinetic of the Relative Wound Density (RWD) was 
analyzed using IncuCyte
TM
 software. All data represented at least three independent 
experiments (n=3). 
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MRP4 Overexpression Inhibits Fibroblast Migration 
 
To further investigate the inhibitory effect of MRP4 on fibroblast cell migration 
we used the conventional in-vitro wound healing assay with parental and MRP4 
overexpressing NIH3T3 cell lines. HA-MRP4 (HA-tag was incorporated in between 751 
and 752 glycine residues at the outer loop of MRP4) was introduced in NIH 3T3 cell 
lines using lentivirus vector and HA-MRP4 overexpressing NIH3T3 cells were selected 
by puromycin (2µg/ml). Those selected cells exhibited higher level of MRP4 expression 
(Figure 4-5A) and significantly higher whole cell PMEA accumulation (Figure 4-5B) 
compare to the control cell. These data indicated that the MRP4 overexpressing stable 
cells have higher level of functionally active MRP4 compare to the control NIH3T3 cells. 
 
To perform the conventional in-vitro scratch wound assay, uniform wound were 
made using pipet tip on the confluent monolayers of control and HA-MRP4 
overexpressing NIH3T3 cells and cell migrations were monitored for 10 hours due to 
slow migration rate of the transfected cells. When we measured the total cell migration 
for 10 hours as a percentage of initial wound length we found that MRP4 overexpressing 
stable cells migrate significantly slower compare to the control NIH3T3 (Figure 4-6) 
indicating a negative effect of MRP4 on fibroblast migration. 
 
These data were further confirmed by high content microscopy. The precise 
wounds were made in the confluent monolayer of control and HA-MRP4 overexpressing 
NIH3T3 cells and images were taken at 1hour interval for 24 hours using the IncuCyte
TM
 
live cell imaging system. The Relative Wound Density (RDW) at every time point was 
measured. Data revealed slower RWD kinetics for NIH3T3 cells overexpressing MRP4 
compare to the control cells (Figure 4-7). Together these in-vitro data suggested an 
inhibitory effect of MRP4 on the fibroblast migration. 
 
 
Mrp4
-/-
 Fibroblasts Migrate Faster in Ex-vivo Skin Explant Assay 
 
In addition the above mentioned in-vitro studies, we performed ex-vivo skin 
explant outgrowth assay for investigating the role of MRP4 on skin fibroblasts. After 
removing the hair, full thickness dorsal skin biopsies (5 mm) were excised from Mrp4
-/-
 
and Mrp4
+/+
 mice. In fibronectin coated wells they were grown for 4 days. The fibroblast 
cells started migrating out from the skin patches after 2days. Coating with fibronectin 
(10µg/ml) helped the fibroblasts to migrate efficiently. Images of the cellular outgrowths 
from each explant were taken by phase contrast microscope and the proximal distance of 
cellular migration was measured by Image J software at day 4 post culture. The 
representative 10X images of cellular outgrowth from skin explants at day 4 post culture 
are shown in Figure 4-8A. An extensive halo of fibroblasts appeared around Mrp4
-/- 
and 
wild type mice skin explants but Mrp4
-/-
 cells migrated 40% more rapidly than the wild 
type fibroblasts (Figure 4-8B).These data suggested that MRP4 plays a key role in 
regulating fibroblasts migration. 
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Figure 4-5. Expression and function of MRP4 in control and HA-MRP4 
overexpressed NIH3T3 cells 
 
(A) The immunoblot images are showing the expressions of MRP4 in control and HA-
MRP4 overexpressed NIH3T3 cells. MRP4 function was measured using [3H] PMEA as 
MRP4 substrate. (B) Bar graphs represent the whole cell PMEA uptake of control and 
HA-MRP4 overexpressed NIH3T3 cells. All data represented at least three independent 
experiments (n=3). * indicated P <0.05. 
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Figure 4-6. Overexpression of MRP4 inhibits NIH3T3 fibroblasts migration 
 
(A)The conventional wound healing assay was performed on the confluent monolayers of 
control and HA-MRP4 overexpressed NIH3T3 cells and images were taken at 0th and 
10th hour. The initial and final wound lengths were calculated and cell migrations were 
represented as a percentage of initial wound length in the bar graph. All data represented 
at least three independent experiments (n=3). * indicated P <0.05. 
 
 
 40 
 
 
 
Figure 4-7. High content microscopy shows slower RWD kinetics for MRP4 
overexpressing NIH3T3 fibroblasts 
 
Control and HA-MRP4 overexpressed NIH3T3 cells were grown on fibronectin-coated 
96-well Essen BioScience ImageLock dishes and the wounds were made precisely using 
96-pin Wound-Maker provided with the IncuCyte
TM
. The kinetic of the Relative Wound 
Density (RWD) was analyzed using IncuCyte
TM
 software. All data represented at least 
three independent experiments (n=3). 
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Figure 4-8. Mrp4
-/-
 fibroblasts show more outgrowths from the skin explants 
 
5mm biopsy patches, isolated from skin of Mrp4
-/-
 mice or wild type mice, were cultured 
with appropriate media in fibronectin-coated (10µg/ml PBS) 6-well dishes. (A) The halo 
of fibroblast cells came out from the skin explant and the images represent the 4th day 
post seeding. (B) The proximal distance of the cellular out growth from the explant was 
represented in bar graph. All data represented at least three independent experiments 
(n=3). * indicated P <0.05. 
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Inhibition of MRP4 Augments the Intracellular Cyclic Nucleotide Levels in 
Fibroblasts 
 
MRP4 is an endogenous efflux transporter of cyclic nucleotides and thereby 
regulates the intracellular cAMP and cGMP dynamics. Among various endogenous 
substrates, MRP4 has been reported to have the high affinity for cAMP (Km = 45µM) 
and cGMP (Km=10/180µM) and these two cyclic nucleotides are very important 
signaling molecules involved in multiple physiological and pathological events (3,19). 
 
To investigate the effect of MRP4 inhibition on intracellular cyclic nucleotide 
dynamics in live fibroblast cells we used the FRET Microscopy. We transiently 
transfected the HA-MRP4 overexpressing NIH3T3 cells either with cAMP sensor CFP-
EPAC-YFP or with cGMP sensor, Cygnet 2.1. The cAMP-dependent conformational 
change in Exchange protein directly activated by cAMP (EPAC) makes it a readily 
targetable FRET-based sensor for measuring intracellular cAMP dynamics by fusing the 
N terminus of EPAC with CFP and C terminus with the YFP analogue (118). Upon 
cAMP binding, EPAC undergoes a conformational change and liberates the catalytic 
domain, which moves CFP and YFP apart from each other to cause a reduced FRET 
signal. 
 
In cGMP-dependent protein kinase (PKG), a relatively larger conformational 
change is induced by cGMP binding and almost a 100-fold higher selectivity was 
observed for cGMP compared to cAMP. Hence PKG has been modified and flanked by 
CFP and an improved pH-insensitive YFP variant to provide an efficient genetically 
encoded FRET-based sensor for cGMP. Cygnet 2.1 has been developed to visualize 
cGMP regulation in real time and space (119). Upon saturation, Cygnet 2.1 undergoes a 
1.4 to 1.5-fold increase in cyan-to-yellow emission, and this dynamic range is 
comparable to the cAMP sensor (128). The mechanism of FRET based sensors specific 
for cAMP and cGMP is illustrated in Figure 4-9. 
 
We were able to monitor the intracellular cAMP and cGMP dynamics with a very 
high temporal and spatial resolution using these two unimolecular FRET based sensors. 
Addition of 20µM of MRP4 inhibitor MK571 (6) induced an increase in the intracellular 
cAMP level in fibroblast cells, which is represented by CFP/FRET emission ratio 
(Figure 4-10). Similarly cGMP level also got increased by the addition of 20 µM MK571 
(Figure 4-11). In both cases the effect was very rapid (within 30 sec). Together these 
data confirmed that inhibition of MRP4 is responsible for increasing both intracellular 
cAMP and cGMP levels. But the effect was more profound on cAMP compared to cGMP 
possibly indicating a higher affinity of MRP4 for cAMP compare to cGMP in fibroblast 
cells. 
 
These FRET based fluorescent sensors not only resolved precise increase in 
intracellular cAMP and cGMP levels, but also provide useful tools to determine the 
functional efficacy of MRP4 inhibitors by monitoring of the inhibition of MRP4-
mediated cyclic nucleotides efflux in real-time. 
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Figure 4-9. Mechanism of FRET based sensors specific for cyclic nucleotides 
 
The illustration showed the conformation changes in Epac and Cygnet 2.1 sensors upon 
cAMP and cGMP binding respectively. The change in conformation takes the donor and 
acceptor fluorophores apart from each other, which results in a reduced FRET signal. 
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Figure 4-10. Inhibition of MRP4 augments intracellular cAMP levels 
 
The pseudocolor images of CFP/FRET, before and 5 minute after addition of MK571 
(20µM) for cells expressing cAMP sensor, were shown and the line graph indicated the 
intracellular cAMP dynamics before and after addition of MK571 as a change in 
CFP/FRET ratio. Images in each panel were captured from the same field of view. Color 
bar showed the magnitude of the emission ratio. All data represented at least three 
independent experiments (n=3). 
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Figure 4-11. Inhibition of MRP4 augments intracellular cGMP levels 
 
The pseudocolor images of CFP/FRET, before and 5 minute after addition MK571 
(20µM) for cells expressing cGMP sensor, were shown and the line graph indicated 
intracellular cGMP dynamics before and after addition of MK571 as a change in 
CFP/FRET ratio. Images in each panel were captured from the same field of view. Color 
bar showed the magnitude of the emission ratio. All data represented at least three 
independent experiments (n=3). 
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Increased Accumulation of Intracellular Cyclic Nucleotides in Mrp4
-/-
 MEFs 
 
As an efflux transporter of cyclic nucleotides, MRP4 can regulate the intracellular 
cAMP and cGMP levels. Therefor in the absence of MRP4 there should be a diminished 
cyclic nucleotides efflux rate and augmented intracellular cAMP/cGMP levels. Using the 
highly sensitive FRET based cAMP sensor (CFP-EPAC-YFP) and cGMP sensor (Cygnet 
2.1) we monitored the intracellular cyclic nucleotide levels in Mrp4
-/-
 and Mrp4
+/+
 MEFs. 
When we transfected Mrp4
-/-
 and Mrp4
+/+
 MEFs with cAMP sensor we found that in the 
absence of MRP4 the Mrp4
-/-
, MEFs show a higher basal level of intracellular cAMP 
(Figure 4-12) compare to the MEFs which endogenously express MRP4. When we 
treated the cAMP sensor transfected cells with 10µM forskolin, a global elevator of 
cAMP, and 100µM IBMX, a nonspecific phosphodiesterase (PDE) inhibitor, the increase 
in cAMP level was higher in Mrp4
-/-
 MEFs compare to the Mrp4
+/+
 MEFs. We also 
observed that the effect of forskolin and IBMX on cAMP level was stronger compare to 
MRP4 inhibition. 
 
Similarly when we transfected Mrp4
-/-
 and Mrp4
+/+
 MEFs with cGMP sensor we 
found that in the absence of MRP4 the Mrp4
-/-
 MEFs show a higher basal level of 
intracellular cGMP (Figure 4-13) compare to the MEFs that endogenously express 
MRP4. After treatment with zaprinast, a specific PDE5 inhibitor, to the cGMP sensor 
transfected fibroblasts the intracellular cGMP level increased more in Mrp4
-/-
 MEFs than 
in Mrp4
+/+
 MEFs. But after addition of zaprinast, there was a transient increase in cGMP 
level whereas a sustained increase in cAMP level was obtained after forskolin and IBMX 
treatment. However these data suggested that Mrp4
-/-
 MEFs contain elevated levels of 
cyclic nucleotide in basal condition and show a higher rise in cAMP and cGMP levels 
upon forskolin-IBMX and zaprinast treatment respectively. 
 
However, we and other have already shown the effect of MRP4 on intracellular 
cyclic nucleotide dynamics and cyclic nucleotides are involved in many hallmark steps of 
cell migration. Therefore we rationalized that the MRP4-mediated alteration of 
intracellular cyclic nucleotide levels are important for the regulation of fibroblast 
migration. 
 
 
Mrp4
-/-
 Fibroblasts Exhibit Moderately Elevated Levels of Cyclic Nucleotide 
 
Using competitive immunoassays specific for cAMP and cGMP we further 
noticed higher levels of intracellular cAMP and cGMP in MRP4-deficient MEFs. In these 
competitive immunoassays, a polyclonal antibody for cAMP or cGMP competitively 
bound with cyclic nucleotides present in the standards or sample, or an alkaline 
phosphatase molecule conjugated cyclic nucleotides (Figure 4-14). Subsequent 
incubation with substrate produced yellow color and the intensity of the color was 
inversely proportional to the concentration of cyclic nucleotides. Protein concentrations 
were measured for each sample and cAMP concentrations were represented as pmole per 
mg of total protein for each sample. 
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Figure 4-12. MRP4 deficient MEFs have moderately higher level intracellular 
cAMP 
 
Mrp4
-/-
 or Mrp4
+/+
 MEFs were transfected with FRET based cAMP sensor, CFP-EPAC-
YFP. The pseudocolor images of CFP/FRET before and 5 minute after addition of 
forskolin (10µM) and IBMX (100µM) were shown and bar graphs represented the 
CFP/FRET ratio in basal condition and after the treatment in Mrp4
-/-
 or Mrp4
+/+
 MEFs. 
Images in each panel were captured from the same field of view. Color bar showed the 
magnitude of the emission ratio. All data represented at least three independent 
experiments (n=3). * indicated P <0.05. 
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Figure 4-13. MRP4 deficient MEFs have moderately higher level intracellular 
cGMP 
 
Mrp4
-/-
 or Mrp4
+/+
 MEFs were transfected with FRET based cGMP sensor, Cygnet 2.1. 
The pseudocolor images of CFP/FRET before and 5 minute after addition of zaprinast 
(200µM) were shown and the bar graphs represented the CFP/FRET ratio in basal 
condition and after the treatment in Mrp4
-/-
 or Mrp4
+/+
 MEFs. Images in each panel were 
captured from the same field of view. Color bar showed the magnitude of the emission 
ratio. All data represented at least three independent experiments (n=3). 
* indicated P <0.05. 
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Figure 4-14. Competitive immunoassay for cyclic nucleotides 
 
Illustrations showed steps involved in competitive immunoassay for cAMP and cGMP. 
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The competitive immunoassay mediated measurement of cAMP showed that in 
basal condition, Mrp4
-/-
 MEFs contain moderately higher levels of intracellular cAMP 
compare to the Mrp4
+/+ 
 MEFs. Treatment of Mrp4
+/+
 MEFs with 10µm forskolin and 
100µM IBMX for 10 minutes, increased the intracellular cAMP level to a much higher 
extent compare to the Mrp4
-/-
MEFs (Figure 4-15). The data suggested that the 
intracellular cAMP level can be moderately regulated by MRP4 whereas forskolin and 
IBMX treatment can strongly elevate the intracellular cAMP levels. 
 
Similarly the competitive immunoassay mediated measurement of cGMP showed 
that in basal condition, Mrp4
-/-
 MEFs contain moderately higher levels of intracellular 
cGMP compare to the Mrp4
+/+ 
 MEFs (Figure 4-16). Therefore both our FRET based 
and ELISA based measurement of cyclic nucleotides confirmed that MRP4 can regulate 
the intracellular cAMP and cGMP levels and due to reduced efflux transportation, Mrp4
-/-
 
MEFs contain moderately higher levels of cyclic nucleotide compare to the wild type 
cells. 
 
Given that previous studies showed the effects of cyclic nucleotides on cell 
migration, we rationalized that MRP4-mediated regulation of fibroblast migration is also 
cyclic nucleotide-dependent. 
 
 
Attenuated MEFs Migration in the Presence of Excessive cAMP 
 
We demonstrated that the inhibition of MRP4 leads to accumulation of more 
cAMP inside the cells and results in an increased migration rate. As the importance of 
cAMP and PKA in directional migration is well established (97,98,100), we rationalized 
that the global cAMP inducing agent forskolin, and a non-specific phosphodiesterase 
inhibitor IBMX should also regulate cell migration in a similar fashion. Forskolin 
activates the enzyme adenylyl cyclase and stimulate cAMP synthesis whereas IBMX 
nonspecifically inhibits cAMP degradation by different isoforms of PDEs. 
 
The strong elevation of cAMP with forskolin and reduced degradation with 
IBMX treatment led to a robust increase in intracellular cAMP level. Hence we tried to 
find the effect of forskolin and IBMX treatment on MEFs migration. To perform the 
conventional in-vitro scratch wound assay, uniform wound were made using pipet tip on 
the confluent monolayers of wild type MEFs treated with DMSO or forskolin-IBMX. 
Cell migrations were monitored for 6 hours. When we measured the total cell migration 
for 6 hours as a percentage of initial wound length we found that forskolin-IBMX treated 
MEFs migrated significantly slower compare to the DMSO treated MEFs (Figure 4-17) 
indicating a negative effect of forskolin-IBMX treatment on fibroblast migration. We 
used high content microscopy to further confirm the data. The precise wounds were made 
in the confluent monolayer of wild type MEFs treated with DMSO or forskolin-IBMX 
and images were taken at 1hour interval for 18 hours using the IncuCyte
TM
 live cell 
imaging system. The Relative Wound Density (RDW) at every time point was measured. 
Data revealed slower RWD kinetics for forskolin-IBMX treated MEFs compare to the 
DMSO treated MEFs (Figure 4-18). 
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Figure 4-15. ELISA-based measurement of cAMP 
 
Bar graph represented the intracellular cAMP levels in Mrp4
-/-
 MEFs, Mrp4
+/+ 
MEFs and 
forskolin (10µM) and IBMX (100µM) treated Mrp4
+/+ 
MEFs. All data represented at 
least three independent experiments (n=3). * indicated P <0.05. 
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Figure 4-16. ELISA-based measurement of cGMP 
 
Bar graph represented the intracellular cGMP levels in Mrp4
-/-
 MEFs and Mrp4
+/+ 
MEFs. 
All data represents at least three independent experiments (n=3). * indicated P <0.05. 
 
 
  
 53 
 
 
 
Figure 4-17. Forskolin and IBMX inhibit MEFs migration in conventional wound 
healing assay 
 
The conventional wound healing assay was done with the DMSO or forskolin (10µM) 
and IBMX (100µM) treated Mrp4
+/+
 MEFs and images were taken at 0th and 6th hour. 
The initial and final wound lengths were calculated and cell migrations as a percentage of 
initial wound length were represented in the bar graph. All data represented at least three 
independent experiments (n=3). * indicated P <0.05. 
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Figure 4-18. High content microscopy shows slower RWD kinetics for forskolin 
and IBMX treated MEFs 
 
DMSO or forskolin (10µM) and IBMX (100µM) treated Mrp4
+/+
 MEFs were grown on 
fibronectin-coated 96-well Essen BioScience ImageLock dishes and the wounds were 
made precisely using 96-pin Wound-Maker provided with the IncuCyte
TM
. The kinetic of 
the Relative Wound Density (RWD) was analyzed by IncuCyte
TM
 softwere. All data 
represented at least three independent experiments (n=3). 
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Inhibition of MRP4 Elevates Polarized cAMP in Migrating Fibroblasts 
 
In contrast to the moderate cAMP elevation in absence of MRP4, the robust 
increase in cAMP levels by forskolin and IBMX treatment significantly inhibited the 
fibroblast migration rate. To investigate the opposing effect of forskolin and IBMX 
treatment and inhibition of MRP4, we monitored the cAMP dynamics in those cells using 
the CFP-PKA regulatory subunit and YFP-PKA catalytic subunit as FRET based cAMP 
sensor. Binding of cAMP to the PKA-regulatory subunit induces the release of catalytic 
subunits and therefore diminishes the FRET signal, followed by an increase in the donor-
to-FRET ratio (129,130). 
 
We transfected the NIH 3T3 cells with those bimolecular FRET based sensor. 
After 10 min of treatment with DMSO, MK571 or forskolin and IBMX, we monitored 
the cAMP dynamics in those migrating fibroblasts. The migrating fibroblasts were 
polarized into leading and trailing edges. We found that inhibition of MRP4 increases the 
cAMP levels near the leading edge of a migration fibroblast whereas the forskolin-IBMX 
treatment causes a robust increase in the cAMP levels all over the cell (Figure 4-19). 
 
These data indicated that by inhibiting MRP4 we can elevate the cAMP levels 
mostly near the leading edge and can augment cell polarization. In contrast forskolin and 
IBMX treatment diminished the cell polarization by increasing the cAMP level 
throughout the cells. Cell polarization is very important for directional cell migration, and 
accumulation of cAMP preferentially at the leading edge induces polarized PKA 
activation which is the hall mark step for directional cell migration (100,101). Therefore 
forskolin and IBMX which strongly elevate the intracellular cAMP level had an 
inhibitory effect on MEF cell migration whereas inhibition of MRP4 which moderately 
increases the cAMP level inside the cell, stimulated cell migration. 
 
 
Biphasic Effect of cAMP on MEF Cell Migration 
 
We observed that the effect of MRP4 inhibition on fibroblast migration is 
opposite to the effect of forskolin and IBMX treatment. This paradoxical effect of cAMP 
on cell migration compelled us to investigate how cyclic nucleotides can regulate cell 
migration in a concentration dependent manner. To investigate the effect of cAMP on 
fibroblast migration we treated the MEFs with different concentrations of cell permeable 
cpt-cAMP (0, 10, 20, 50, 100 and 200µM). Then we performed the conventional in-vitro 
scratch wound assay by making uniform wound using pipet tip on the confluent 
monolayers of wild type MEFs treated with different concentrations of cpt-cAMP. Cell 
migrations were monitored for 6 hours. When we measured the total cell migration for 6 
hours as a percentage of initial wound length we found that cAMP has a biphasic effect 
on cell migration. Up to 20 µM cAMP can stimulate cell migration in a dose dependent 
fashion but after that it started decreasing the migration rate (Figure 4-20). These data 
indicated that cAMP can regulate cell migration in a concentration dependent fashion. 
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Figure 4-19. Inhibition of MRP4 elevates cAMP accumulation at the leading edge 
 
NIH3T3 cells were transfected with CFP-PKA regulatory subunit and YFP-PKA catalytic 
subunit as FRET based cAMP sensor. The pseudocolor images represented the 
CFP/FRET signal of DMSO, forskolin and IBMX and MK571 treated fibroblasts. Images 
in each panel were captured from the same field of view. Color bar showed the 
magnitude of the emission ratio. 
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Figure 4-20. cAMP has a biphasic effect on fibroblast cell migration 
 
The conventional wound healing assay was done with Mrp4
+/+
 MEFs and different 
concentrations (0, 10, 20, 50, 100 and 200µM) of cell permeable cpt-cAMP. Images were 
taken with 100X magnification at the 0th and 6th hour. The initial and final wound 
lengths were calculated, and the fold increases in cell migration rates were representedin 
the line graph. The intracellular cAMP concentration were measured by competitive 
immunoassay for Mrp4
-/-
, Mrp4
+/+
 and forskolin (10µM) and IBMX (100µM) treated 
Mrp4
+/+
 MEFs. The Intracellular cAMP levels corresponding to those cells were 
indicated by arrows. All data represented at least three independent experiments (n=3). 
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Quantification of Intracellular cAMP Concentrations 
 
Next we quantitated the intracellular cAMP concentrations in Mrp4
-/-
, Mrp4
+/+
 
and forskolin (10µM) and IBMX (100µM) treated Mrp4
+/+
 MEFs using competitive 
immunoassay specific for cAMP. We trypsinized the cells, counted the number of cells in 
each sample and measured the radius of a single Mrp4
-/-
or Mrp4
+/+
 MEF cell using phase 
contrast microscopy. We found that the average radius (r) of those cells is ≈ 10µm. We 
calculated the volume (V) of each cells accordingly (V= 4/3 πr3) and quantitated the 
intracellular concentration of cAMP in µM for each types of cells after estimating the 
total protein concentrations for each sample (111). 
 
We noticed that the intracellular concentration of cAMP for Mrp4
+/+
 MEFs is ≈ 7 
µM and for Mrp4
-/-
 MEFs ≈ 10 µM. But a prolonged treatment with 10 µM forskolin and 
100 µM IBMX (>30min) strongly increased the cAMP concentration up to ≈ 42µM 
(Figure 4-20). The absence of MRP4 increased the intracellular cAMP concentration to a 
level where cAMP exerts its stimulating effect on cell migration. But an extended 
treatment with forskolin and IBMX increased the concentration further up and as a 
consequence cell migration got inhibited. Together these data indicated that a moderate 
elevation of cyclic nucleotide levels stimulates cell migration but that a further increase 
leads to inhibition. 
 
 
Biphasic Effect of cGMP on MEF Cell Migration 
 
After revealing that cAMP has a biphasic effect on cell migration we tried to 
investigate the effect of cGMP on fibroblasts migration. Therefore we treated the MEFs 
with different concentrations of cell permeable cpt-cGMP (0, 10, 20, 50, 100 and 
200µM). Then performed the conventional in-vitro scratch wound assay by making 
uniform wound using pipet tip on the confluent monolayers of wild type MEFs treated 
with different concentrations of cpt- cGMP. Cell migrations were monitored for 6 hours. 
When we measured the total cell migration for 6 hours as a percentage of initial wound 
length we found that cGMP has a similar biphasic effect but the concentration range for 
stimulation was broader and effect was milder than that for cAMP. It stimulated 
fibroblast migration up to 100µM concentration and then exerted the inhibitory effect 
(Figure 4-21). 
 
These data indicated that effect of cAMP on cell migration is stronger compare to 
cGMP. At physiological concentrations the effect of cGMP on fibroblast migration was 
rather stimulatory. The inhibitory effect was found at much higher concentration which is 
not physiologically relevant. Additionally our FRET studies suggested that MRP4 has 
higher affinity for cAMP at least in fibroblast cells. Therefore we rationalized that cAMP 
plays a more important role in MRP4-dependent regulation of fibroblast migration. 
However balanced and highly controlled intracellular cyclic nucleotide levels are 
implicated as important in fibroblast migration. 
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Figure 4-21. cGMP has a biphasic effect on fibroblast cell migration 
 
The conventional wound healing assay was done with Mrp4
+/+
 MEFs and different 
concentrations (0, 10, 20, 50, 100 and 200µM) of cell permeable cpt-cGMP. Images were 
taken with 100X magnification at the 0th and 6th hour. The initial and final wound 
lengths were calculated, and the fold increases in cell migration rates were represented in 
the line graph. All data represented at least three independent experiments (n=3). 
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Identification of MRP4 Interactome 
 
We have already demonstrated that MRP4 plays important role in the regulation 
of fibroblast migration via alteration of cyclic nucleotide levels. In order to completely 
understand the effect of MRP4 on migratory phenomenon, it is required to identify the 
proteins that act as downstream effectors of MRP4 in regulating cell migration. Therefore 
we wanted to isolate MRP4 interactome and identify the interacting partners that are 
known to be involved in migration related signaling cascades. We stably overexpressed 
HA-MRP4 in HEK293 cells using lentivirus vector and purified MRP4 from those cells 
using anti–HA beads. Figure 4-22 showed the Coomassie-stained gel of immune-
precipitated full-length HA-MRP4 and its interacting partners. 
 
Then the major bands in the HA-MRP4 immunoprecipitated lane were subjected 
to mass spectrometric (MS) analysis. MS analysis confirmed that we indeed purified full 
length MRP4. We also identified hundreds of MRP4 interacting proteins. The functions 
of MRP4 interacting partners were obtained from http://www.uniprot.org. The complete 
list of MRP4 interactome, classified based on their molecular function, was provided in 
Tables 4-1 to 4-11. 
 
We also calculated the Mowse score to select the protein with high Mowse score 
and remove the randomized interactions of low Mowse score. In peptide mass 
fingerprinting a Mowse score represents “similarity score” based on the matching N 
peaks probability by random chance. A high Mowse score will be assigned to a protein 
sequence if it shows a high frequency of matched peaks or when a peak is exclusive. 
 
We found that a large number of MRP4 interacting proteins including actin are 
cytoskeleton related protein. That indicated the possible role of MRP4 in regulating 
cytoskeleton dynamics during cell migration. With the help of Ingenuity Pathway 
Analysis we assigned MRP4 as seed and the MRP4 interacting proteins as high 
confidence (HC) interactome. To investigate the importance of MRP4 interactome in 
various migration related signaling events, we checked the interconnectivity between 
MRP4 and its interacting partners in the context of cell migration. 
 
We used the “shortest path” explorer which also includes the intermediate 
proteins and molecules involved in those pathway based on literature and experimental 
evidences (Figure 4-23).We assigned MRP4 as seed (orange) and the MRP4 interacting 
proteins as high confidence (HC) interactome (pink) and indicated the intermediate 
proteins involved in the pathways based on literature and experimental evidences (Blue). 
 
Subsequently we identified that several migration related signaling cascades 
including actin polymerization and focal adhesion complex formation, are regulated by 
certain nodes in the interactome network and cAMP and cGMP were also found to be the 
important nodal points in the entire network. 
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Figure 4-22. Immunoprecipitation of full-length HA-MRP4 for mass-spectrometric 
analysis 
 
MRP4 was affinity purified using anti HA-beads from HA-MRP4 overexpressed HEK 
293 cells. The Coomassie-stained gel showed the immunoprecipitated full-length HA-
MRP4 and its interacting partners. 
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Table 4-1. List of chaperones identified by mass-spectrometric analysis in the 
MRP4 interactome 
 
Protein  Mowse score 
Midasin   65.37 
Heat shock cognate 71 kDa protein isoform 1  29.13 
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Table 4-2. List of cytoskeleton related proteins identified by mass-spectrometric 
analysis in the MRP4 interactome 
 
Protein  Mowse score 
Dynein heavy chain domain-containing protein 1 isoform 1  184.98 
Beta actin variant  59.71 
Actin, gamma-enteric smooth muscle isoform 1 precursor  59.35 
Rab GTPase-activating protein 1   54.99 
Microtubule-actin cross-linking factor 1 isoform a   50.30 
Nesprin-2  49.53 
Polytrophic  48.02 
Myosin-XVI isoform 2  42.85 
Cytoplasmic FMR1 interacting protein 2  42.85 
Myosin-9  41.26 
Dynein heavy chain 3, axonemal  38.81 
Kinesin-1 heavy chain  37.45 
Kinesin heavy chain isoform 5A  37.45 
Keratin, type I cytoskeletal 12  34.66 
Gamma-tubulin complex component 5 isoform a  31.78 
Cytokeratin 8  31.19 
Titin isoform novex-3  156.41 
Myotubularin related protein 8, isoform CRA_a  145.03 
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Table 4-3. List of transcription regulators identified by mass-spectrometric 
analysis in the MRP4 interactome 
 
Protein  Mowse score 
Poly (ADP-ribose) polymerase family, member 3 isoform a variant  27.81 
WD repeat domain 19, isoform CRA_a  31.92 
RNA-binding protein FUS isoform 2  165.49 
Transcription elongation factor B polypeptide 1 isoform b  9.68 
Chromosome 3 open reading frame 21  97.58 
RNA-binding protein EWS isoform 3  63.10 
Leucine-rich repeat-containing protein 47  50.15 
Leucine-rich repeat-containing protein 31  49.30 
DNA polymerase epsilon, catalytic polypeptide  48.82 
Terminal uridylyl transferase 4 isoform b  45.81 
Zinc finger, CCHC domain containing 11  45.81 
Leucine-rich repeat and IQ domain-containing protein 1  44.53 
Bromo-domain adjacent to zinc finger domain 1B  44.24 
KIAA0553 protein [Homo sapiens]  42.40 
TAF15 RNA polymerase II,  35.94 
hnRNP G protein  34.28 
NF45 protein  34.01 
Tho2  32.99 
TGFB-induced factor homeobox 1  32.19 
KIAA0309  31.78 
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Table 4-4. List of receptor proteins identified by mass-spectrometric analysis in 
the MRP4 interactome 
 
Protein  Mowse score 
Olfactory receptor 2T35  823.07 
Rap guanine nucleotide exchange factor (GEF) 1  31.78 
ALS2  31.43 
G protein-coupled receptor 155  20.86 
FLJ00279 protein  39.19 
TBC1 domain family, member 2B, isoform CRA_c  31.78 
FERM, RhoGEF and pleckstrin domain-containing protein 2  15.68 
SH2 domain containing 3C  94.63 
Arf-GAP with SH3 domain, ANK repeat and PH domain-
containing protein 1 
 77.41 
Adenylate cyclase type 5 isoform 1  47.13 
Bile acid receptor isoform 3  48.85 
Mannose receptor  15.47 
Thyroid hormone receptor-associated protein complex component 
TRAP220 
 13.78 
CAS  10.36 
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Table 4-5. List of phosphorylation related proteins identified by mass-
spectrometric analysis in the MRP4 interactome 
 
Protein  Mowse score 
Guanine nucleotide exchange factor Lbc  37.51 
KIAA0213  37.45 
Alpha-1 antitrypsin  34.04 
cAMP-specific phosphodiesterase 8A  21.32 
Serine/threonine-protein kinase Nek6 isoform 4  13.47 
PAS-kinase  12.98 
Janus kinase and microtubule-interacting protein 1  15.52 
PI-3-kinase ATX  27.27 
Mitogen- and stress-activated protein kinase-2  31.78 
Titin, isoform CRA_a  201.51 
Titin, isoform CRA_e  198.33 
Dual specificity protein kinase TTK isoform 1  140.17 
Muscle, skeletal, receptor tyrosine kinase  140.17 
Small intestine SPAK-like kinase  73.13 
Obscurin isoform a  54.51 
Apoptosis signal-regulating kinase 2  42.85 
Serine/threonine protein kinase  39.17 
Serine/threonine-protein kinase D2 isoform A  10.35 
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Table 4-6. List of metabolism related proteins identified by mass-spectrometric 
analysis in the MRP4 interactome 
 
Protein  Mowse score 
Group III secreted phospholipase A2  31.03 
PSMD1 protein  29.95 
CLEC16A protein  29.15 
Monooxygenase, DBH-like 1, isoform CRA_a  141.39 
Monooxygenase, DBH-like 1  141.39 
Tyrosine hydroxylase isoform D1b,2,8,9  42.85 
KIAA0455 protein  36.42 
Polypeptide N-acetylgalactosaminyl transferase 3  33.39 
Aspartyl/asparaginyl beta-hydroxylase isoform a  31.78 
Cytochrome P450, family 2, subfamily C, polypeptide 18 variant  26.78 
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Table 4-7. List of ECM and adhesion related proteins identified by mass-
spectrometric analysis in the MRP4 interactome 
 
Protein  Mowse score 
SCO-spondin precursor  27.37 
Desmoplakin I  27.43 
Trypsin-3 isoform 1 preproprotein  140.17 
Plasminogen  64.03 
Galectin-3-binding protein  42.95 
ATP-dependent zinc metalloprotease YME1L1 isoform 3  42.85 
LEKTI precursor  37.51 
Collagen alpha-6(VI) chain precursor  34.88 
Reelin isoform b  9.43 
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Table 4-8. List of ubiquitination related proteins identified by mass-
spectrometric analysis in the MRP4 interactome 
 
Protein  Mowse score 
SSA1  86.2 
F-box only protein 38 isoform b  73.13 
Suppressor of cytokine signaling 7  69.75 
Probable ubiquitin carboxyl-terminal hydrolase FAF-Y  47.37 
Ubiquitin-conjugating BIR-domain enzyme APOLLON  33.91 
Cullin 7  27.87 
Autophagy-related protein 13 isoform 2  10.50 
Cul-3  133.00 
Midline-1 isoform 3  38.21 
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Table 4-9. List of apoptosis related proteins identified by mass-spectrometric 
analysis in the MRP4 interactome 
 
Protein  Mowse score 
Periaxin, isoform CRA_b  142.88 
unc-13 homolog B (C. elegans), isoform CRA_b  142.88 
Caspase 3, apoptosis-related cysteine peptidase, isoform CRA_b  74.81 
hCG1743181  34.88 
Huntingtin  33.80 
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Table 4-10. List of ion channels and transporter proteins identified by mass-
spectrometric analysis in the MRP4 interactome 
 
Protein  Mowse score 
Potassium channel  31.78 
Multidrug resistance-associated protein  26.67 
BRCA2  13.10 
ATP-binding cassette, sub-family A (ABC1), member 13, isoform 
CRA_a 
 13.09 
Potassium channel subfamily K member 3  12.59 
Sodium channel protein type 9 subunit alpha  12.18 
 
 
  
 72 
Table 4-11. List of various other proteins identified by mass-spectrometric 
analysis in the MRP4 interactome 
 
Protein  Mowse score  Function 
Histone-arginine methyl 
transferase CARM1 
 42.85  Methylation 
p400 SWI2/SNF2-related 
protein 
 58.7  Histone acetylation 
ASH1  91.4  Histone-lysine N-methyl 
transferase activity 
PDZ domain-containing protein 
8 
 19.15  Regulation of cell 
morphogenesis 
NuMA protein  36.56  Structural molecule activity 
at apical part of cell 
APC  68.28  Cell migration, adhesion. 
Wnt pathway 
Protein unc-13 homolog C  146.29  Exocytosis, metal ion and 
diacylglycerol binding 
KIAA1032 protein  142.88  Metal ion and diacylglycerol 
binding 
256 kD golgin  45.10  Golgi to plasma membrane 
protein transport 
KIAA0109  42.85  Protein transport, coated pit 
Growth arrest-specific 8, 
isoform CRA_c [ 
 142.88  Antiproliferative, sperm 
motility 
Sister chromatid cohesion 
protein PDS5 homolog B  
 33.41  Mitotic sister chromatid 
cohesion 
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Figure 4-23. Ingenuity Pathway Analysis (IPA) for MRP4 interactome 
 
Ingenuity Pathway Analysis showed the interconnectivity between MRP4 interactome in 
the context of cell migration. We assigned MRP4 as seed (orange) and the MRP4 
interacting proteins as high confidence (HC) interactome (pink) and indicated the 
intermediate proteins and molecules involved in the pathways based on literature and 
experimental evidences (Blue). 
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Actin and MRP4 Interaction 
 
Interestingly using Ingenuity Pathway Analysis (IPA) we demonstrated that 
significant numbers MRP4 interacting partners are involved in various signaling cascades 
associated with the process of cell migration. This network and system biology based 
approach provided a comprehensive perspective of MRP4 interactome in migration 
related signaling events. Additionally we found that via alteration of cyclic nucleotide 
levels, MRP4 can regulate some of its interacting partners that play important roles in 
various signaling processes associated with cell migration. Given that no previous report 
of a direct interaction between MRP4 and actin was found, we identified a novel 
interaction between actin and MRP4 by mass-spectrometric analysis of the MRP4 
interactome. 
 
Notably we identified actin as an integral part of MRP4 containing 
macromolecular complexes. It has been known for long that actin cytoskeleton plays 
important role during the course of cell migration and dynamic rearrangement of actin at 
the leading edge promotes the localized protrusion formation and efficient cell migration 
(77,131). During cell migration, actin cytoskeletons get highly polymerized to form 
cortical actin at the cortex region, a narrow zone just beneath the plasma membrane at the 
leading edge. Before studying the effect of MRP4 on actin dynamics we verified the 
endogenous association of actin with MRP4 in fibroblasts. Therefore we 
immunoprecipitated MRP4 from Mrp4
+/+
 and Mrp4
-/-
 MEFs using anti-MRP4 rabbit 
polyclonal antibody. Our immunoblot data showed no MRP4 was immunoprecipitated in 
Mrp4
-/-
 MEFs but a significant amount of MRP4 was immunoprecipitated by anti-MRP4 
antibody in Mrp4
+/+
 MEFs. We also found that actin is co-immunoprecipitated with 
MRP4 (Figure 4-24). This data confirmed that actin interacts with MRP4 in fibroblast 
cells. 
 
To further confirm the MRP4-actin interaction we monitored their co-
localizations in fibroblasts cells. We performed immunofluorescence staining for actin 
and MRP4 using phalloidin Alexa Fluor 488 and anti-MRP4 rabbit polyclonal antibody-
anti Rabbit Alexa Fluor 568 respectively in NIH3T3 cells. We observed that MRP4 
expressed and co-localized with actin predominantly at the plasma membrane of NIH3T3 
cells (Figure 4-25). 
 
Next we performed immunofluorescence staining for actin and MRP4 using 
phalloidin Alexa Fluor 488 and anti-MRP4 rabbit polyclonal antibody -anti Rabbit Alexa 
Fluor 568 respectively in the confluent monolayers of Mrp4
+/+
 and Mrp4
-/-
 MEFs. We 
found that a significant population of actin is co-localized with MRP4 in Mrp4
+/+
 MEFs 
compare to Mrp4
-/-
 MEFs which do not express any MRP4 (Figure 4-26). The 
quantification of actin and MRP4 co-localization was done using Imaris 7.7 Software. 
Altogether our immunofluorescent and co-immunoprecipitations data supported the mass 
spectroscopy based detection of MRP4 and actin interaction and led us to hypothesize the 
possible role of actin as a key downstream effector protein for MRP4-mediated regulation 
of fibroblast migration. 
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Figure 4-24. Co-immunoprecipitation of actin with MRP4 from Mrp4
+/+
 MEFs 
 
Endogenous MRP4 was immunoprecipitated from Mrp4
+/+
 and Mrp4
-/-
 MEFs and 
immunoblot data showed that actin is co-immunoprecipitated with MRP4. 
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Figure 4-25. MRP4 co-localizes with actin predominantly at the plasma membrane 
in NIH3T3 cells 
 
Co-localization of MRP4 and actin in NIH3T3 cells was shown using anti-MRP4 
antibody (red) and Phalloidin antibody (green) by confocal fluorescence microscopy 
using 40 X objective, normal rabbit IgG was used as control. 
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Figure 4-26. MRP4 co-localizes with actin in wild type MEF cells 
 
Co-localization of MRP4 and actin in Mrp4
+/+
 and Mrp4
-/-
 MEFs was shown using anti-
MRP4 antibody (red) and Phalloidin  antibody (green) by confocal fluorescence 
microscopy using 20 X objective and bar graph represented the percentage co-
localization of MRP4 and F-actin compare to total F-actin. All data represented at least 
three independent experiments (n=3). * indicated P <0.05. 
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Actin Restricts MRP4 on the Cell Membrane 
 
After revealing the fact that MRP4 can form a macromolecular complex with 
actin at the plasma membrane, we tried to see the effect of actin cytoskeleton on MRP4 
mobility at the cell membrane. As actin cytoskeleton has already been known to play an 
important role in restricting several membrane proteins at specific domains of plasma 
membrane (121,132) we hypothesized that actin can also restrict the surface mobility of 
MRP4 molecules in fibroblasts. 
 
To investigate the effects of actin cytoskeleton disruption on MRP4 mobility, we 
used Latrunculin B which disrupts actin cytoskeleton by inducing de-polymerization of 
actin filament. The dynamics of individual protein molecules in the plasma membrane of 
a live cell can be successfully monitored by SPT (133), therefore we used the SPT 
method to investigate the effects of actin cytoskeleton disruption on HA-MRP4 dynamics 
in live NIH3T3 cells. 
 
HA-MRP4 was labeled with biotin anti-HA antibody and then streptavidin-
conjugated Qdot-655 was added to tag the MRP4 protein on the plasma membrane. As 
the HA tag on MRP4 protein was located between Gly 751 and 752 residues at the 4
th
 
extracellular loop, antibodies can efficiently bind to the tag from outside without 
penetrating the cell. Figure 4-27 showed that HA-MRP4 overexpressed cells were 
successfully tagged with the Qdot-655 in presence but not in absence of biotin anti-HA 
antibody. These data confirmed the specific labeling of HA-MRP4 with Qdot-655 in the 
NIH3T3 cells. 
 
After labeling we monitored that mobility of the individual Qdot-655 as a 
representative of single MRP4 molecule using the particle-tracking module of SlideBook 
4.2 software. The software also generated trajectories for single Qdot-655 and calculated 
the mean square displacement and diffusion coefficient as index of lateral diffusion. To 
monitor changes in the lateral diffusion of MRP4 in fibroblasts with cytoskeletal 
disruption, cells were pretreated with Lat B (1 μM, 30 min) or DMSO (as control), and 
were also added to the buffer during the course of the experiment. 
 
We found that in control condition the mean diffusion coefficient of MRP4 is 
0.016μm2/s. That denoted a confined diffusion of MRP4, which is comparable with the 
diffusion coefficient of other membrane proteins (121). Treatment with Lat B (1 μM), 
increased the diffusion coefficient of MRP4 almost by 2 fold (mean diffusion coefficient 
0.03μm2/s) with longer trajectory paths (Figure 4-28A) and faster overall mobility 
kinetics (Figure 4-28B and Figure 4-29). 
 
Together our SPT data suggested that actin plays pivotal role in restricting MRP4 
at specific micro-domains of plasma membrane and therefore can influence the MRP4-
mediated compartmentalized signaling. 
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Figure 4-27. Qdot-655 labeled NIH 3T3 cells overexpressing HA-MRP4 
 
Representative bright field and quantum dot labeled images of HA-MRP4 overexpressed 
NIH3T3 cells treated with or without biotin α-HA antibody. 
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Figure 4-28. Disruption of actin cytoskeleton increases overall mobility kinetics of 
MRP4 
 
(A) SPT of HA-MRP4 in NIH3T3 cells represented by pseudocolor images showing 
trajectories for individual HA -MRP4 molecule with DMSO or Lat B treatment. (B) 
Representative mean squared displacement curve showed the overall mobility kinetics of 
HA-MRP4 in DMSO or Lat B treated cells (n = 5-6 cells, 150–250 trajectories). 
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Figure 4-29. Disruption of actin cytoskeleton increases MRP4 mobility on cell 
membrane 
 
Histograms represented the diffusion coefficients of a population of HA-MRP4 in the 
plasma membrane of DMSO or Lat B treated NIH3T3 cells. 
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Effect of Actin Cytoskeleton Disruption on MRP4 Function 
 
Our SPT data suggested that disruption of actin cytoskeleton by Lat B enhances 
the lateral diffusion of MRP4 molecules on the cell surface. Next we tried to investigate 
the effect of Lat B treatment on MRP4 function using HA-MRP4 overexpressed HEK293 
cells. We used 8-FcA as a fluorescent substrate for MRP4 (115) and measured the efflux 
of 8-FcA by MRP4, two hours after treatment with DMSO, MK571 and Lat B. We found 
that MK571 significantly reduced the MRP4 mediated efflux of 8-FcA but Lat B did not 
show any effect on 8-FcA efflux rate (Figure 4-30). These data indicated that disruption 
of actin cytoskeleton does not alter the function of MRP4. However we were not ruling 
out the possibility of an altered MRP4-mediated compartmentalized signaling upon 
disruption of actin cytoskeleton. 
 
 
MRP4 Deficient Fibroblasts Exhibit Altered β-Actin Dynamics 
 
Though our SPT data confirmed that actin cytoskeleton is responsible for 
confining MRP4 localization but we did not find any direct impact of actin cytoskeleton 
disruption on MRP4 function. Hence we tried to see if MRP4 itself can exert an effect on 
cytoskeleton rearrangement during the course of cell migration. 
 
To study the effect of MRP4 on actin dynamics, we fixed the wounded 
monolayers of Mrp4
+/+
 and Mrp4
-/-
 MEFs and stained them with Alexa Fluor 488 
conjugated phalloidin antibody. During cell migration, actin cytoskeleton gets highly 
polymerized at the cortex region, a narrow zone just beneath the plasma membrane at the 
leading edge, and this actin-network is called cortical actin. We observed that there is a 
thick cortical actin band at the wound edge of wild type and Mrp4
-/-
 MEFs. Notably the 
F- actin intensity at the wound edge was significantly higher in Mrp4
-/-
 MEFs compare to 
wild type MEFs (Figure 4-31). 
 
Similarly in an individual migrating Mrp4
-/-
 MEF the F-actin level was also much 
higher compare to Mrp4
+/+
 MEF (Figure 4-32). Additionally in wild type cells distinct 
MRP4 expressions were observed in the lamellipodia. These observations suggested that 
at the leading edge MRP4 exerts a negative impact on cortical actin organization and 
therefore the MRP4 deficient fibroblasts exhibit more intense cortical actin and faster 
migration rate. 
 
 
Increased cAMP Accumulation at the Leading Edge of Migrating Mrp4
-/- 
MEFs 
 
The polarized activation of cAMP dependent kinase PKA is an essential early step 
for directional cell migration and it is also involved in actin polymerization and in the 
regulation of cytoskeleton dynamics (99,100,102,104). 
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Figure 4-30. Fluorescence based assay for MRP4 function 
 
MRP4 function was measured using 8-FcA as MRP4 substrate. Bar graph represented the 
amount of effluxed 8-FcA in HA-MRP4 overexpressed HEK293 cells treated with 
DMSO, MK571 or Lat B. All data represented at least three independent experiments 
(n=3). * indicated P <0.05. 
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Figure 4-31. MRP4 deficient fibroblasts exhibit enhanced cortical actin network at 
the wound edge 
 
Cortical actin dynamics at the wound edges were shown in Mrp4
+/+
 and Mrp4
-/-
 MEFs 
using Phalloidin  antibody (green) by confocal fluorescence microscopy using 20X 
objective and bar graph represented the total actin intensity at the wound edge in Mrp4
+/+
 
and Mrp4
-/-
 MEFs. All data represented at least three independent experiments (n = 3). 
* indicated P <0.05. 
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Figure 4-32. MRP4 deficient fibroblasts exhibit an altered β-actin dynamics 
 
Actin dynamics in migrating Mrp4
+/+
 and Mrp4
-/-
 MEFs were shown using Phalloidin 
antibody (green) and anti-MRP4 antibody (red) by confocal fluorescence microscopy 
using 20 X objective. 
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We have already demonstrated that in migrating fibroblast, inhibition of MRP4 
enhances the polarized cAMP level at or near the leading edge. Here we used CFP and 
YFP tagged PKA regulatory and catalytic subunits as FRET based cAMP sensor to 
visualize the spatiotemporal dynamics of cAMP at the wound edge of the Mrp4
+/+
 and 
Mrp4
-/-
 MEFs. 
 
In both cell types we observed polarized accumulation of cAMP at the leading 
edge (Figure 4-33A). We also found that the total intracellular cAMP levels is higher in 
Mrp4
-/-
 MEFs compare to the Mrp4
+/+
 MEFs (Figure 4-33B). Additionally the difference 
in cAMP levels between leading edge and cell body is significantly higher in Mrp4
-/-
 
MEFs compare to the Mrp4
+/+
 MEFs (Figure 4-33C). 
 
These data indicated that in absence of MRP4 there is an enhanced accumulation 
of cAMP at or near the leading edge of a migrating fibroblast and these altered cAMP 
dynamics plays an important role in regulating cell migration. 
 
 
MRP4 Deficient Fibroblasts Exhibit Higher PKA Activity 
 
As we found a higher level of cAMP in Mrp4
-/-
 MEFs compare to the Mrp4
+/+
 
MEFs, we rationalized that the overall PKA activity should also be higher in Mrp4
-/-
 
MEFs. We measured the PKA activity by measuring phosphorylation profile of 
immobilized PKA substrate on the microtiter plate in presence of ATP. Antibody specific 
for phospho-PKA substrate recognized the immobilized phosphorylated substrate and got 
detected by peroxidase conjugated anti rabbit IgG. Using this competitive immunoassay 
based method we revealed a significantly higher total PKA activity in cells lacking 
MRP4 (Figure 4-34). 
 
This data was supported by an altered phosphorylation status of PKA substrate 
VASP in the absence of MRP4. VASP contains three phosphorylation sites Ser-157, Ser-
239, and Thr-278 for cyclic nucleotide dependent serine and threonine kinases- PKA and 
PKG (134,135). VASP can be phosphorylated by PKA at Ser 157 and it causes a shift in 
the molecular mass of the protein in SDS-PAGE from 46 to 50 kDa. This indicated that, 
that phosphorylation induces a change in the secondary structure of VASP (136). 
Phosphorylation of VASP elevates its activity by relieving some inhibitory interactions. 
However the phosphorylation of VASP may reduce the velocity of protrusion formation 
but helps in the formation of persistent lamellipodia. Therefore the phosphorylation of 
VASP plays important role in fibroblast migration (39,49). 
 
To demonstrate the expression of VASP in fibroblast cells, we fixed the wounded 
monolayers of Mrp4
+/+
 and Mrp4
-/-
 MEFs and stained them with anti-VASP rabbit 
monoclonal antibody and Alexa Fluor 488 conjugated anti rabbit antibody. We observed 
that VASP is expressed predominantly at the tip of lamellipodia for both of the cell types. 
Expression levels of VASP at the wound edges were found to be similar for Mrp4
+/+
 and 
Mrp4
-/-
 MEFs (Figure 4-35). 
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Figure 4-33. MRP4 deficient fibroblasts exhibit increased total and polarized 
cAMP levels 
 
(A) The pseudocolor images of CFP/FRET with 60X magnification for Mrp4
+/+
 and 
Mrp4
-/-
 MEFs expressing cAMP sensor were shown. (B) The bar graphs represented the 
CFP/FRET ratio indicating total intracellular cAMP levels in Mrp4
+/+
 and Mrp4
-/-
 MEFs. 
(C) The bar graphs represented the difference in CFP/FRET signal between leading edge 
and cell body of Mrp4
+/+
 and Mrp4
-/-
 MEFs. Images in each panel were captured from the 
same field of view. Color bar showed the magnitude of the emission ratio. All data 
representd at least three independent experiments (n=3). * indicated P <0.05. 
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Figure 4-34. MRP4-deficient fibroblasts exhibit higher PKA activity 
 
Bar graph represented total intracellular PKA activity in Mrp4
+/+
 and Mrp4
-/-
 MEFs 
measured by competitive immunoassay. All data represented at least three independent 
experiments (n=3). * indicated P <0.05. 
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Figure 4-35. Expression of VASP in MEFs 
 
VASP expressions in Mrp4
+/+
 and Mrp4
-/-
 MEFs were shown using anti- VASP antibody 
(green) by confocal fluorescence microscopy using 20 X objective. 
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When we investigated the level of phosphorylated VASP in MEFs, we found that 
Mrp4
-/-
MEFs exhibit higher level of phosphorylation of VASP at Ser157 than the wild 
type cells suggesting a higher PKA activity in the absence of MRP4 (Figure 4-36). 
 
 
Mrp4
-/-
 MEFs Exhibit Higher Levels of Polarized PKA Activity 
 
Via the activation of their effector kinase (e.g., PKA and PKG) cyclic nucleotides 
primarily execute their function in cells. FRET can be used as a powerful tool for 
visualizing the PKA activity using the specific phosphorylation substrate peptide for 
PKA flanked by CFP and YFP as sensor (137-140). The membrane targeted, forkhead-
associated domain 1 (FHA1) and the PKA substrate sequence LRRATLVD containing 
improved FRET based sensor for PKA (pmAKAR3) was used to monitor the polarized 
PKA activation in the leading edge, which is an essential early hallmark step for 
directional cell migration (100,141,142). The use of this FRET-based kinase sensors 
provide useful tool for the identification of effector kinases that regulate various signaling 
processes. They also contribute in detecting the correlation between cyclic nucleotide 
dynamics and kinase activity in real time and space. Phosphorylation of pmAKAR3 by 
PKA catalytic subunit increases the FRET signal between CFP and YFP by inducing a 
conformational change. Insertion of a lipid modification domain to the sensor causes 
targeting of the sensor specifically to the plasma membrane (143). 
 
To check the specificity of pmAKAR3 for PKA activity we treated HEK293 cells 
transfected with pmAKAR3 or the point mutant pmAKAR3-TA, which contains a 
threonine-to-alanine mutation at substrate region for PKA and therefore irresponsive to 
PKA phosphorylation, with 25 µM of forskolin. We found an increase in FRET signal in 
cells expressing pmAKAR3 but that of the cells expressing pmAKAR3-TA remained 
unaltered (Figure 4-37A). The basal FRET levels were also higher for cells expressing 
pmAKAR3 compare to the cells expressing pmAKAR3-TA (Figure 4-37B). These data 
indicated that pm AKAR3 sensor is very specific for PKA activity. 
 
We made precise wound on the confluent monolayers of MEF cells transfected 
with pmAKAR3 sensor. We selected cells expressing pmAKAR3 sensor particularly at 
the wound edge. By monitoring the FRET signal we observed a polarized PKA activity at 
the wound edge in both Mrp4
-/-
 and Mrp4
+/+
 MEFs (Figure 4-38A). We also found that 
the total intracellular PKA activity is higher in Mrp4
-/-
 MEFs compare to the Mrp4
+/+
 
MEFs (Figure 4-38B). Additionally the difference in PKA activity between leading edge 
and trailing edge is also significantly higher in Mrp4
-/-
 MEFs compare to the Mrp4
+/+
 
MEFs (Figure 4-38C). 
 
Together these observations indicated that in absence of MRP4 the elevated level 
of cAMP induces the polarized PKA activation which in turn augments cell migration by 
facilitating the cortical actin network formation at the leading edge. 
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Figure 4-36. PKA-dependent phosphorylation of VASP in Mrp4
-/-
 and Mrp4
+/+ 
MEFs 
 
Immunoblot data showed that PKA-dependent phosphorylation of VASP and bar graph 
represented the ratio of phosphorylated VASP to the total VASP in Mrp4
-/-
 and Mrp4
+/+ 
MEFs. All data represented at least three independent experiments (n = 3). 
* indicated P <0.05. 
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Figure 4-37. FRET based measurement of PKA activity using pmAKAR3 sensor 
 
(A) The pseudocolor images of N-FRET with 60X magnification for HEK293 cells 
transfected with pmAKAR sensor and pmAKAR-TA sensor were shown. (B) The line 
graphs represented the change in N-FRET levels after treatment with forskolin. Images in 
each panel were captured from the same field of view. Color bar showed the magnitude 
of the N-FRET. All data represents at least three independent experiments (n=3). 
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Figure 4-38. MRP4 deficient fibroblasts exhibit increased total and polarized PKA 
activity 
 
(A) The pseudocolor images of N-FRET with 60X magnification for Mrp4
+/+
 and Mrp4
-/-
 
MEFs expressing pmAKAR sensor were shown. (B) The bar graphs represented the N-
FRET signal indicating total intracellular PKA activity in Mrp4
+/+
 and Mrp4
-/-
 MEFs. (C) 
The bar graphs represented the difference in N-FRET signal between leading edge and 
trailing edge of Mrp4
+/+
 and Mrp4
-/-
 MEFs. Images in each panel were captured from the 
same field of view. Color bar showed the magnitude of the N-FRET. All data represented 
at least three independent experiments (n=3). * indicated P <0.05. 
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Disruption of Actin Cytoskeleton Abrogates the Effect of MRP4 on Cell Migration 
 
Using immunofluorescence staining in the wounded monolayers of MEFs we 
revealed that much thicker cortical actin bands are formed at the wound edge of Mrp4
-/- 
MEFs compare to the Mrp4
+/+ 
MEFs. The formation of cortical actin network at the 
leading edge is an important hall mark step for directional cell migration. These data 
indicated that MRP4 must exert its effect on cell migration by alteration of actin 
cytoskeleton dynamics at the leading edge of a migrating fibroblast. 
 
The altered actin dynamics in MRP4-deficient cells suggested that the effect of 
MRP4 on cell migration is actin-dependent. Therefore we investigated the effect of actin 
disruption on MRP4 dependent cell migration. Uniform wound were made using pipet tip 
on the confluent monolayers of Mrp4
-/-
 and Mrp4
+/+ 
MEFs treated with DMSO or Lat B. 
Then cell migrations were monitored only for 6 hours to minimize the effect of cell 
proliferation. 
 
In agreement with our previous study, the in vitro wound healing assay revealed 
that Mrp4
-/-
 MEFs move significantly faster compare to the Mrp4
+/+
 MEFs but the after 
Lat B (1µl) treatment both of the cell types migrated at a similar rate which is much 
slower than the basal migration rate of wild type fibroblasts (Figure 4-39A). In this assay 
cell migration was monitored for 6 hours and was represented as a percentage of initial 
wound length (Figure 4-39B). 
 
Next we investigated the effect of Lat B treatment on MRP4 expression using 
western blot. But our immunoblot data suggested that Lat B has no effect on MRP4 
expression in MEFs (Figure 4-39C). 
 
Additionally we used high-content microscopic technique to confirm the effect of 
Lat B on fibroblast migration in vitro. After making precise wounds on the confluent 
monolayer of MEFs, cells were treated with DMSO or Lat B (1µl) and images were taken 
at 1hour intervals for 12 hours using the IncuCyte
TM
 live cell imaging system and the 
relative wound density was monitored for each time point. 
 
We did not continue the assay for longer time as the effect of Lat B was not 
sustained after 12 hours. Though the basal RWD kinetics is higher for Mrp4
-/-
 MEFs, Lat 
B treatment reduced the overall migration rate and both types of MEFs exhibited similar 
RWD kinetics through the entire period of time (Figure 4-40). 
 
Altogether these data indicated that disruption of actin cytoskeleton attenuates the 
fibroblasts migration rate. Actin played an important role in regulating cAMP-dependent 
regulation of fibroblast migration by MRP4. Disruption of actin polymerization 
abrogated the effect of MRP4 on fibroblasts motility without affecting MRP4 expression 
levels. Therefore we concluded that actin is the downstream target of MRP4 for 
regulating fibroblast migration. 
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Figure 4-39. Disruption of actin cytoskeleton abrogates the effect of MRP4 on cell 
migration 
 
(A) The conventional wound healing assay was performed on the in Mrp4
+/+ 
and Mrp4
-/- 
MEFs treated with DMSO or Lat B, and images were taken with 10X magnification at 
the 0th and 6th hour. (B) The initial and final wound lengths were calculated, and cell 
migrations as a percentage of initial wound length were represented in the bar graph. (C) 
The immune-blots data showed the expression of MRP4 in Mrp4
+/+
 and Mrp4
-/-
 MEFs 
treated with DMSO or Lat B. All data represented at least three independent experiments 
(n=3). * indicated P <0.05. 
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Figure 4-40. High content microscopy shows similar RWD kinetics for Lat B 
treated Mrp4
-/-
 and Mrp4
+/+ 
MEFs 
 
Mrp4
+/+ 
and Mrp4
-/- 
MEFs were grown on fibronectin-coated 96-well Essen BioScience 
ImageLock dishes, and the wounds were made precisely using the 96-pin Wound-Maker 
provided with the IncuCyte
TM
. The kinetics of the relative wound density (RWD) was 
analyzed using IncuCyte
TM
 software after treatment with DMSO or Lat B. All data 
represented at least three independent experiments (n = 3). 
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Inhibition of PKA Attenuates the Effect of MRP4 on Cell Migration by Alteration of 
Cortical Actin Dynamics 
 
As we observed that MRP4 exerts its effect on cell migration by modulating the 
actin polymerization at the cell front, and previous studies showed the importance of 
PKA in regulating actin based cell migration (99,100,103), we hypothesized that PKA act 
as an intermediate effector protein for transmitting the effect of MRP4 on cortical actin 
dynamics. 
 
Therefore we investigated the effect of PKA inhibitor H-89 on MRP4-dependent 
cell migration. Uniform wound were made using pipet tip on the confluent monolayers of 
Mrp4
-/-
 and Mrp4
+/+
 MEFs treated with DMSO or 50µM of H-89 (144). Then cell 
migrations were monitored only for 6 hours to minimize the effect of cell proliferation. 
 
In agreement with our previous study, the in vitro wound healing assay revealed 
that Mrp4
-/-
 MEFs move significantly faster compare to the Mrp4
+/+
 MEFs but the after 
H-89 (50µM) treatment both of the cell types migrated at a similar rate with the basal 
migration rate for wild type fibroblasts (Figure 4-41A). In this assay cell migration was 
monitored for 6 hours and was represented as a percentage of initial wound length 
(Figure 4-41B). 
 
Our immunoblot data suggested that H-89 reduces the PKA mediated 
phosphorylation of VASP and therefore a diminished phosphorylated VASP level was 
detected in H-89 treated Mrp4
-/-
 and Mrp4
+/+
 MEFs. However H-89 has no effect on 
MRP4 and total VASP expressions in MEFs (Figure 4-41C). 
 
Additionally we used high-content microscopic technique to confirm the effect of 
PKA inhibition on fibroblast migration in vitro. After making precise wounds in the 
confluent monolayer of MEFs, cells were treated with DMSO or H-89 (50µM) and 
images were taken at 1hour intervals for 24 hour using the IncuCyte
TM
 live cell imaging 
system and the relative wound density was monitored for each time point. We found that 
up to 8 hour, both of the cell types treated with H-89 migrate at a similar rate with the 
basal migration rate for wild type fibroblasts. After that the H-89 treated cells started 
migrating with a much slower rate compare to the control wild type cells. However the 
RWD kinetics for H-89 treated Mrp4
+/+
 and Mrp4
-/-
 MEFs were identical for the entire 24 
hours period of time (Figure 4-42). These data indicated that inhibition of PKA can 
abrogate the effect of MRP4 on fibroblast migration. 
 
To understand the inhibitory effect of H-89 on cell migration, we treated wounded 
monolayers of Mrp4
+/+
 and Mrp4
-/-
 MEFs with 50 µM of H-89. After 4 hours cells were 
fixed and stained with Alexa Fluor 488 conjugated phalloidin antibody. The 
immunofluorescent data revealed that inhibition of PKA diminished the cortical actin 
network formation at the wound edge and both Mrp4
+/+
 and Mrp4
-/- 
MEFs showed 
similar but reduced level of F-actin at the wound edge after treatment with PKA inhibitor 
H-89 (Figure 4-43). 
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Figure 4-41. Inhibition of PKA attenuates the effect of MRP4 on cell migration 
 
A) The conventional wound healing assay was performed on the Mrp4
+/+
 and Mrp4
-/-
 
MEFs treated with DMSO or PKA inhibitor H89, and images were taken with 10X 
magnification at the 0th and 6th hour. (B) The initial and final wound lengths were 
calculated, and cell migrations as a percentage of initial wound length were represented 
in the bar graph. (C) The immune-blots data showed the expression of MRP4, phospho 
VASP and total VASP in Mrp4
+/+
 and Mrp4
-/-
 MEFs treated with DMSO or H89. All 
data represented at least three independent experiments (n = 3). * indicated P <0.05. 
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Figure 4-42. High content microscopy shows similar RWD kinetics for H-89 
treated Mrp4
-/-
 and Mrp4
+/+ 
MEFs 
 
Mrp4
+/+ 
and Mrp4
-/- 
MEFs were grown on fibronectin-coated 96-well Essen BioScience 
ImageLock dishes, and the wounds were made precisely using the 96-pin Wound-Maker 
provided with the IncuCyte
TM
. The kinetics of the relative wound density (RWD) was 
analyzed using IncuCyte
TM
 software after treatment with DMSO or H-89. All data 
represented at least three independent experiments (n = 3). 
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Figure 4-43. Inhibition of PKA induces multiple pseudopod formation in Mrp4
-/-
 
and Mrp4
+/+ 
MEFs 
 
Actin dynamics at the wound edges of migrating Mrp4
+/+
 and Mrp4
-/-
 MEFs were shown 
using Phalloidin antibody (green) and anti-MRP4 antibody (red) by confocal microscopy 
using 20 X objective. 
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Most importantly inhibition of PKA induced the formation of multiple 
pseudopods for both of the cell types denoting that PKA activity is essential for proper 
cell polarization, localized protrusion formation at the direction of cell migration and 
fine-tuned cell migration (Figure 4-43). 
 
Together these results confirmed that PKA acts as a downstream effector of 
MRP4 for executing its effects on actin polymerization and therefore on the overall cell 
migration. 
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CHAPTER 5.    DISCUSSION* 
 
 
Cyclic Nucleotides Regulate Cell Migration 
 
Our study demonstrated that inhibition of MRP4 stimulates fibroblast cell 
migration by moderately increasing the intracellular cyclic nucleotides levels. In the year 
1999, MRP4 was first identified as an endogenous efflux transporter of nucleoside-based 
antiviral drugs in human T-lymphoid cell line (3,7). 
 
Besides conferring drug resistance, MRP4 was also found to regulate diverse 
physiological and pathological phenomena via alteration of the intracellular concentration 
of its different endogenous substrates (27,145). However, among several endogenous 
substrates MRP4 has been reported to have very high affinity for cAMP (Km = 45 µM) 
and cGMP (Km = 10/180 µM), and these two cyclic nucleotides play important roles as 
signaling molecules in many physiological and pathological events (18,19). 
 
These elegant but simple secondary messengers regulate different complex 
biological events, mostly via the activation of their target kinases (35-37,45,146,147). 
Being a highly integrated multi-step process, cell migration plays a central role in 
embryonic development, tissue repair, cancer, immune response and many other 
physiological and pathological events (50,51). 
 
Cyclic nucleotides play important roles in the signaling cascades associated with 
the various stages of the cell migration, either directly or by activating their effector 
kinases (146). 
 
Polarized activation of cAMP-dependent protein kinases (PKA) at the leading 
edge of a migrating cell is important for maintaining cell polarity and pseudopod 
formation. The PKA-mediated directional migration requires activation of Rac GTPase 
(100,101,103). Conversely, Rac-induced lamellipodia formation was inhibited by 
elevated levels of cAMP (105). On the other hand, cGMP-dependent kinase (PKG) was 
down regulated during VSMC cell migration (106). 
 
But by phosphorylating VASP, PKG can relieve the negative effect of VASP on 
the lamellipodia stability and maintain the repetitive behavior of cell migration (39). 
These complex and equivocal effects of cyclic nucleotides on cell migration ensure the 
importance of a tightly regulated and balanced intracellular cyclic nucleotide level for 
fine-tuned cell migration. 
 
                                                 
 
*
 Adapted with permission. This research was originally published in The Journal of Biological Chemistry. 
Sinha, C., Ren, A., Arora, K., Moon, C. S., Yarlagadda, S., Zhang, W., Cheepala, S. B., Schuetz, J. D., and 
Naren, A. P. Multi-drug resistance protein 4 (MRP4)-mediated regulation of fibroblast cell migration 
reflects a dichotomous role of intracellular cyclic nucleotides, (2013) J Biol Chem, 288, 3786-3794. © the 
American Society for Biochemistry and Molecular Biology. 
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MRP4 Regulates Intracellular Cyclic Nucleotide Dynamics and Cell Migration 
 
Together with our ex vivo skin explant outgrowth assay, the high-content 
microscopy and conventional wound healing data indicated significantly increased cell 
migration for MRP4-deficient MEF cells. These data suggested an important role for 
MRP4 in regulating fibroblast migration. In similar experiments, inhibition of MRP4 by 
MK571 significantly increased MEFs migration, whereas overexpression of MRP4 
reduced the rate of wound healing indicating a negative effect of MRP4 on overall 
fibroblast migration. 
 
To understand the mechanism behind this process of regulation, we focused on 
different endogenous substrates for MRP4 that are important for migratory events. As 
MRP4 exhibits high affinities for cAMP and cGMP and these two second messengers 
were already reported to be involved in different hallmark steps of cell migration (97), we 
monitored the effect of MRP4 inhibition on intracellular cyclic nucleotide levels in 
fibroblasts. Using FRET-based sensors specific for cAMP and cGMP, we observed that 
inhibition of MRP4 by MK571 increases intracellular concentrations of both cAMP and 
cGMP. But the effect was milder for cGMP compared to cAMP, indicating the higher 
affinity of MRP4 for cAMP in fibroblasts. 
 
Using the same sensors, we found higher basal levels of cAMP and cGMP for 
Mrp4
-/-
 MEFs. The intracellular cyclic nucleotide levels are regulated by 
phosphodiesterase-mediated hydrolysis and by the process involving active transport out 
of the cell (20,47). Zaprinast inhibits the breakdown of cGMP by PDE5 and thus 
increases the intracellular cGMP level (148). In the absence of MRP4, the efflux of 
cGMP from the cell was reduced, and therefore there was an increased accumulation of 
intracellular cGMP. Hence the zaprinast-induced elevation of cGMP was also higher for 
Mrp4
-/-
 MEFs. Forskolin elevates the intracellular cAMP level by stimulating adenylate 
cyclase (149,150). Therefore forskolin and the nonspecific phosphodiesterase inhibitor 
IBMX caused a huge and prolonged increase in the intracellular cAMP level in MEFs 
(151). Because of less cAMP efflux, the MRP4-deficient cells accumulated more cAMP 
than Mrp4
+/+
 MEFs upon treatment with forskolin and IBMX. 
 
We found a sustained and robust increase in cAMP level by forskolin and IBMX 
treatment which results in inhibited fibroblast migration. Whereas an augmented 
migration rate was observed by inhibiting MRP4 that induces a moderate increase in 
cAMP level, mostly near the leading edge of a migrating fibroblast. Thus by elevation of 
cAMP level at the cell front, MRP4 inhibition facilitates fibroblast polarization, a 
hallmark step for directional cell migration. 
 
In wound healing studies with cell-permeant cyclic nucleotides analogues, cpt-
cAMP enhanced the fibroblasts migration up to 20 µM in a concentration-dependent 
manner but after that, the effect was inhibitory. At basal condition the intracellular cAMP 
concentration of Mrp4
-/-
 MEFs was moderately higher than that of Mrp4
+/+
 MEFs (about 
1.5 fold), and it fell within the stimulatory concentration range (1-20 µM). A prolonged 
treatment (> 30 min) with forskolin and IBMX, however, increased the level further 
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(about 6.5 fold), at which concentration the effect of cAMP is no longer stimulatory, 
rather inhibitory to cell migration. 
 
These data explained the opposing effects of MRP4 inhibition and forskolin, 
IBMX treatment, on cell migration. A similar but milder biphasic effect was also 
observed for cpt-cGMP which stimulated cell migration when used in concentrations up 
to 100 µM. Hence, highly regulated intracellular cyclic nucleotides levels are implicated 
as important in fine-tuned fibroblasts migration. 
 
 
Role of Actin and PKA in Cell Migration 
 
Cell migration is very important for embryonic development, wound healing, 
immune response and a defective cell migration may lead to various pathologic 
conditions like vascular diseases, tumor formation and cancer metastasis (37,51,52,70). 
Establishment of cell polarity is indispensable for directional cell migration and restricted 
activation cAMP dependent kinase at the leading edge is one of the key initiators for 
promoting localized protrusions and thereby inducing directional cell migration 
(100,103). 
 
We also found that inhibition of MRP4 elevates the polarized cyclic cAMP at the 
leading edge of a migrating fibroblast and this in turn augments the overall cell migration 
rate. Studies have shown that at the leading edge, PKA activates small GTPases like Rac 
and Cdc42 which are important for lamellipodia and filopodia formation respectively 
during cell migration (50,72,76,99). 
 
The phosphorylation activated Rac induces the WASP/ WAVE-mediated 
activation of Apr 2/3 which binds at 70
o 
to the sides or tips of pre-existing actin and 
promotes the formation of dendritic actin network containing lamellipodia(50,51,73). 
Additionally PKA dependent phosphorylation of VASP can also regulate the actin 
polymerization and hence can control the protrusion formation in the direction of cell 
migration (75). 
 
 
Actin Is an Integral Part of MRP4 Interactome 
 
In this study we purified MRP4 containing macromolecular complex from 
HEK293 cells and using the network and system biology based approach we provided a 
comprehensive perspective of MRP4 interactome in migration related signaling events. 
Notably we identified actin as an integral part of MRP4 containing macromolecular 
complexes and found that these two proteins associate with each other predominantly at 
the plasma membrane of fibroblast cells. The interaction between actin and MRP4 helped 
in restricting MRP4 in specific micro-domains of plasma membrane and disruption of 
actin cytoskeleton caused almost two fold increases in lateral diffusion rate of MRP4 at 
the cell surface. 
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Though we did not find any direct effect of actin disruption on MRP4 function, 
we are not ruling out the possible effect of actin on MRP4 dependent compartmentalized 
signaling. While investigating the effect of MRP4 on actin dynamics, we observed that 
the migrating Mrp4
-/-
 MEFs exhibit a higher degree of actin polymerization and therefore 
much intense cortical actin band at or near the leading edge compare to the wild type 
cells. The simultaneous localization of MRP4 at the lamellipodia suggested a viable role 
of MRP4 in regulating cytoskeleton dynamics and actin rearrangement at the cell 
protrusions. 
 
 
MRP4 Regulates PKA Activity in Fibroblast Cells 
 
Question still remained how MRP4 regulates actin cytoskeleton. As we already 
knew that inhibition of MRP4 leads to an polarized elevation of cAMP in migrating 
fibroblasts, and cAMP/PKA can regulate the actin based cell migration (17,99), we 
looked at the variability in cAMP dynamics between Mrp4
+/+
 and Mrp4
-/-
 MEFs. We 
used PKA based FRET sensor to monitor the spatiotemporal dynamics of cAMP at the 
wound edge of migrating fibroblast. In agreement with previous studies (100,103), we 
observed elevated cAMP levels at the leading edges of both types of migrating 
fibroblasts. Not only the total intracellular cAMP but also the polarized cAMP levels 
were found to be significantly higher in Mrp4
-/-
 MEFs compare to the Mrp4
+/+
 
fibroblasts. Using FRET based membrane bound PKA sensor pmAKAR3 we also found 
that not only the total intracellular PKA activity but also the polarized PKA activity was 
significantly higher in Mrp4
-/-
 MEFs compare to the Mrp4
+/+
 fibroblasts. 
 
These data indicated that in absence of MRP4, the increased accumulation of 
cAMP at the leading edge activates more polarized PKA which in turn augments the 
structured extension formation by inducing actin polymerization and therefore improves 
the overall rate of cell migration. 
 
 
PKA and Actin Are Downstream Effectors for MRP4-Dependent Regulation of 
Fibroblast Migration 
 
To further confirm our hypothesis, we studied the effect of actin in regulating 
MRP4 dependent cell migration using wound healing assay. We observed that without 
affecting the MRP4 protein expression, disruption of actin cytoskeleton completely 
abrogates the effect of MRP4 on cell migration and both Mrp4
+/+
 and Mrp4
-/-
 fibroblasts 
start migrating with a similar rate after Lat B treatment. However Lat B treatment 
significantly reduced the overall migration rate for both of the cell types. 
 
To establish the possible role of PKA as an effector protein in this process of 
regulation, we also studied the effect of PKA inhibition on fibroblast migration. In the 
Mrp4
-/-
 fibroblasts, the higher levels of cAMP led to an augmented PKA activity thereby 
elevated VASP phosphorylation at Ser157 residue. But the PKA inhibitor H-89 treatment 
suppressed the pVASP levels in both Mrp4
+/+
 and Mrp4
-/-
 MEFs without affecting total 
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VASP and MRP4 expressions. We found that after inhibition of PKA, both Mrp4
+/+
 and 
Mrp4
-/-
 MEFs migrate with similar rate as the untreated wild type MEFs for 8 h. Though 
the migration rate further reduced after that but still both Mrp4
+/+
 and Mrp4
-/-
 MEFs 
maintained similar RWD kinetics. These data suggested that the effect of PKA inhibition 
is much sustained compare to the Lat B treatment. 
 
When we looked at the actin dynamics in those H-89 treated cells, we observed a 
reduced cortical actin network formation at the wound edges. Most importantly inhibition 
of PKA induced multiple pseudopod formation and impaired directionality in both 
Mrp4
+/+
 and Mrp4
-/-
 MEFs informing a pivotal role of PKA in promoting polarization 
and localized protrusion formation during the course of directional migration. 
 
Together our data suggested that inhibition of MRP4 elevates cAMP levels and 
therefore activates more PKA at or near the leading edge of a migrating fibroblast. This 
confined PKA activation enhanced the cell polarization and is the early hall mark step in 
directional cell migration. 
 
However in absence of MRP4-mediated cAMP efflux, the augmented PKA 
activity stimulated actin polymerization probably via phosphorylation of VASP or 
activation of small GTPase. Therefore it facilitated the formation of restricted and 
localized structured extension specifically at the direction of cell migration (Figure 5-1). 
Hence PKA acts as an intermediate effector protein to convey the effect of MRP4 on the 
downstream target actin cytoskeleton for regulating fibroblast migration. 
 
Although further study is required to identify the intermediate molecules that 
carry the effect of PKA on actin dynamics and to unravel the entire molecular mechanism 
behind the MRP4 dependent cell migration, our study demonstrated a novel cAMP-
dependent mechanism for MRP4-mediated regulation of fibroblast migration where PKA 
and actin play critical roles as downstream targets. 
 
 
Conclusions 
 
In agreement to our findings, the knockdown of MRP4 was reported to enhance 
human retinal vascular endothelial cell migration (126). In contrast, some other studies 
with dendritic cells (145) and arterial smooth muscle cells (23) showed a stimulatory 
effect of MRP4 on cell migration. This dichotomy of MRP4 as an effector for cell 
migration may be related to the ambiguous role of cyclic nucleotides in migration 
associated events and can be explained by the tissue-specific differential expression 
levels of MRP4 and its interactome. Variation in MRP4-mediated regulation of 
intracellular cyclic nucleotide dynamics and differential effects of cyclic nucleotides on 
various cell types could be the major issue. Other endogenous substrates for MRP4 may 
also be involved in the regulation of cell migration (3,34). 
 
Altogether, our findings indicated that MRP4 can negatively regulate fibroblast 
migration, at least in part, via a cyclic nucleotide-dependent manner. 
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Figure 5-1. Schematic representation of mechanism of MRP4 dependent 
fibroblast migration 
 
The figure depicted that inhibition of MRP4 increases the intracellular cAMP levels 
mostly near the leading edge of a migrating fibroblast, which in turn activates PKA. The 
activated PKA increases the VASP phosphorylation and enhances the actin 
polymerization at the cell front and thus facilitates cell migration. 
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Our observation that inhibition of MRP4 increases fibroblast migration warrants 
the use of MRP4 inhibitors like MK571 as new and potential wound healing agents. The 
indirect effect on cancer metastasis should be taken into consideration during the use of 
MRP4 inhibitor for reducing chemotherapy resistance in cancer patients. However 
additional detailed studies are required to investigate the role of MRP4 in different types 
of cancer metastasis. On the other hand, increase in intracellular cAMP level by 
inhibition of MRP4 can be a good strategy to reduce fibroblasts to myofibroblasts 
transformation (65,66) for preventing unwanted tissue fibrosis. 
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